Processing 00000000.tx.1: Insulin Secretory Function Is Impaired in Isolated Human Islets Carrying the Gly972Arg IRS-1 Polymorphism Piero Marchetti1, Roberto Lupi1, Massimo Federici2, Lorella Marselli1, Matilde Masini4, Ugo Boggi4, Silvia Del Guerra1, Giovanni Patan1, Salvatore Piro3, Marcello Anello3, Ettore Bergamini4, Francesco Purrello3, Renato Lauro2, Franco Mosca4, Giorgio Sesti5, and Stefano Del Prato1 1 Department of Endocrinology and Metabolism, Metabolic Unit, University of Pisa, Pisa, Italy 2 Department of Internal Medicine, University of Rome "Tor Vergata," Rome, Italy 3 Department of Endocrinology, University of Catania, Catania, Italy 4 Department of General Pathology, University of Pisa, Pisa, Italy 5 Department of Clinical and Experimental Medicine, University of Catanzaro "Magna Graecia," Catanzaro, Italy  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS REFERENCES  Type 2 (noninsulin-dependent) diabetes results from decreased insulin action in peripheral target tissues (insulin resistance) and impaired pancreatic -cell function. 

Phrase: "Insulin Secretory Function"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0544458:Secretory function [Functional Concept]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "Is"

Phrase: "Impaired in Isolated Human Islets"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086418:Human [Human]
   760   C0205409:Isolated [Functional Concept]
   760   C0221099:Impaired [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]
   760   C1548221:Isolated [Idea or Concept]

Phrase: "Carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the Gly972Arg IRS-1 Polymorphism Piero Marchetti1,"

Phrase: "Roberto Lupi1,"

Phrase: "Massimo Federici2,"

Phrase: "Lorella Marselli1,"

Phrase: "Matilde Masini4,"

Phrase: "Ugo Boggi4,"

Phrase: "Silvia Del Guerra1,"

Phrase: "Giovanni Patan1,"

Phrase: "Salvatore Piro3,"

Phrase: "Marcello Anello3,"

Phrase: "Ettore Bergamini4,"

Phrase: "Francesco Purrello3,"

Phrase: "Renato Lauro2,"

Phrase: "Franco Mosca4,"

Phrase: "Giorgio Sesti5,"

Phrase: "and"

Phrase: "Stefano Del Prato1 1 Department of Endocrinology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0587463:Endocrinology department [Health Care Related Organization]
   748   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "Metabolic Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439148:Unit [Quantitative Concept]
   861   C1519795:Unit [Quantitative Concept]
   861   C1704753:Unit [Manufactured Object]
   861   C1880519:Unit [Quantitative Concept]

Phrase: "University of Pisa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Pisa,"

Phrase: "Italy 2 Department of Internal Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "University of Rome ""Tor Vergata,"" Rome,"

Phrase: "Italy 3 Department of Endocrinology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0587463:Endocrinology department [Health Care Related Organization]
   760   C1704729:Department [Organization]

Phrase: "University of Catania,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Catania,"

Phrase: "Italy 4 Department of General Pathology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C0587490:General pathology department [Health Care Related Organization]
   783   C0587487:Pathology department [Health Care Related Organization]
   753   C1704729:Department [Organization]

Phrase: "University of Pisa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Pisa,"

Phrase: "Italy 5 Department of Clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Experimental Medicine,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0260205:Medicine, Experimental [Research Activity]
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]
   861   C1517586:Experimental [Qualitative Concept]

Phrase: "University of Catanzaro ""Magna Graecia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0041740:University [Manufactured Object,Organization]

Phrase: """ Catanzaro,"

Phrase: "Italy  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0035171:Research Design [Research Activity]
   795   C0035168:research [Research Activity]
   795   C0242481:Research [Research Activity]
   795   C1707689:Design [Activity]
   795   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Type 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441730:Type 2 [Classification]
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(noninsulin-dependent) diabetes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0011860:Non-Insulin Dependent Diabetes [Disease or Syndrome]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0851827:Dependent [Qualitative Concept]
   827   C1701901:Dependent [Qualitative Concept]
   827   C3244310:dependent [Functional Concept]

Phrase: "results from decreased insulin action"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0441472:Action [Functional Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C1274040:Result [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1546471:Result [Idea or Concept]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2825142:Result [Finding]
   760   C3266814:Action [Activity]
   726 E C0547047:Decrease [Quantitative Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in peripheral target tissues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0040300:Tissues [Tissue]
   827   C1521840:Target [Functional Concept]
   827   C2986546:TARGET [Diagnostic Procedure]
   793 E C1547928:Tissue [Intellectual Product]

Phrase: "(insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "impaired pancreatic -cell function."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   875   C0232786:Pancreatic function [Organ or Tissue Function]
   861   C0007613:Cell Function [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1705273:Function [Intellectual Product]
   812   C1948049:Cell [Spatial Concept]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.2: These defects reflect both genetic components and environmental risk factors. 

Phrase: "These defects"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0243067:defects [Functional Concept]
   966 E C1457869:Defect [Functional Concept]
   966 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "both genetic components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "environmental risk factors."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0686732:environmental risk factors [Qualitative Concept]
       E   Environmental Factor
   913   C1516998:Environmental Factors [Functional Concept]
   901   C0035648:risk factors [Quantitative Concept]
   901   C1553898:risk factors [Idea or Concept]
   827   C0035647:Risk [Qualitative Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.3: Recently, the common Gly972Arg amino acid polymorphism of insulin receptor substrate 1 (Arg972 IRS-1) has been associated with human type 2 diabetes. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "the common Gly972Arg amino acid polymorphism of insulin receptor substrate 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0032529:Polymorphism [Genetic Function]
   738   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(Arg972 IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   937   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   840   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   840   C1334133:INSULIN RECEPTOR [Gene or Genome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1710236:Substrate [Manufactured Object]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "has"

Phrase: "been"

Phrase: "associated with human type 2 diabetes."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   833   C0011860:Type 2 Diabetes [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0441730:Type 2 [Classification]
   783   C1320657:Diabetes type [Finding]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0086418:Human [Human]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.4: In this study, we report on some functional and morphological properties of isolated human islets carrying the Arg972 IRS-1 polymorphism. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "report on some functional"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205245:Functional [Functional Concept]
   770   C0542341:Functional [Functional Concept]
   770   C0684224:Report [Intellectual Product]
   770   C0700287:Report [Health Care Activity]
   770   C2700217:Functional [Conceptual Entity]
   770   C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "morphological properties of isolated human islets"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the Arg972 IRS-1 polymorphism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0032529:Polymorphism [Genetic Function]
   799   C1882417:Polymorphism [Qualitative Concept]
   734   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
Processing 00000000.tx.5: Insulin content was lower in variant than control islets (94  47 vs. 133  56 U/islet; P < 0.05). 

Phrase: "Insulin content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "lower in variant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "than control islets"

Phrase: "(94  47"

Phrase: "vs. 133  56 U/islet"

Phrase: "; P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.6: Stepwise glucose increase (1.7 to 16.7 mmol/l) significantly potentiated insulin secretion from control islets, but not Arg972 IRS-1 islets, with the latter also showing a relatively lower response to glyburide and a significantly higher response to arginine. 

Phrase: "Stepwise glucose increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:Increase [Functional Concept]

Phrase: "(1.7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3541329:1-7 [Gene or Genome]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "to 16.7 mmol/l) significantly potentiated insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C1256369:insulin secretion [Cell Function]
   793   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C0036536:secretion [Biologic Function]
   793   C0036537:Secretion [Body Substance]
   793   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1579433:Insulin [Pharmacologic Substance]
   737 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   710 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "from control islets,"

Phrase: "but"

Phrase: "not Arg972 IRS-1 islets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   710   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "with the latter also"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a relatively lower response to glyburide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "a significantly higher response to arginine."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
Processing 00000000.tx.7: Proinsulin release mirrored insulin secretion, and the insulin-to-proinsulin ratio in response to arginine was significantly lower from Arg972 IRS-1 islets than from control islets. 

Phrase: "Proinsulin release mirrored insulin secretion,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1718242:Proinsulin/Insulin [Quantitative Concept]
   840   C1256369:insulin secretion [Cell Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the insulin-to-proinsulin ratio in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0456603:Ratio [Quantitative Concept]
   748   C1547037:Ratio [Intellectual Product]

Phrase: "to arginine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "significantly lower from Arg972 IRS-1 islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0441994:Lower [Spatial Concept]
   742   C1548802:Lower [Body Location or Region]
   742   C2003888:Lower [Activity]

Phrase: "than"

Phrase: "from control islets."
Processing 00000000.tx.8: Glucose utilization and oxidation did not differ in variant and wild-type islets at both low and high glucose levels. 

Phrase: "Glucose utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042153:utilization [Functional Concept]

Phrase: "and"

Phrase: "oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ in variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205419:Variant [Qualitative Concept]

Phrase: "and"

Phrase: "wild-type islets at both low"

Phrase: "and"

Phrase: "high glucose levels."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0428548:glucose levels [Laboratory or Test Result]
   901   C0860803:high glucose [Finding]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.9: Electron microscopy showed that Arg972 IRS-1 -cells had a severalfold greater number of immature secretory granules and a lower number of mature granules than control -cells. 

Phrase: "Electron microscopy"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0026019:Electron Microscopy [Laboratory Procedure]
  1000   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   861   C0013852:Electron [Quantitative Concept]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C3463986:Electron [Bird]
   789 E C0013850:Electronic [Manufactured Object]
   789 E C0205288:Microscopic [Qualitative Concept]
   789 E C1547561:Electronic [Idea or Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Arg972 IRS-1 -cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   859   C0030281:Insulin Cell [Cell]
   841   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   734   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "had"

Phrase: "a severalfold greater number of immature secretory granules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "a lower number of mature granules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "than control -cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.10: In conclusion, Arg972 IRS-1 islets have reduced insulin content, impaired insulin secretion, and a lower amount of mature secretory granules. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "Arg972 IRS-1 islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "have"

Phrase: "reduced insulin content,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "impaired insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "a lower amount of mature secretory granules."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]
Processing 00000000.tx.11: These alterations may account for the increased predisposition to type 2 diabetes in individuals carrying the Gly972Arg amino acid polymorphism of IRS-1.  

Phrase: "These alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515926:Alteration [Idea or Concept]

Phrase: "may"

Phrase: "account for the increased predisposition"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0012655:Predisposition [Clinical Attribute]
   760   C0205217:Increased [Quantitative Concept]
   760   C0220898:Predisposition [Organism Attribute]
   760   C0442805:Increased [Functional Concept]
   760   C1551359:account [Idea or Concept]
   760   C2741673:Account # [Clinical Attribute]
   760   C2981730:Account [Classification]

Phrase: "to type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "in individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the Gly972Arg amino acid polymorphism of IRS-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0032529:Polymorphism [Genetic Function]
   739   C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.12: INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS REFERENCES  Type 2 (non-insulin-dependent) diabetes is the most frequent form of diabetes, and it affects 5% of the population in Western countries (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Type 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441730:Type 2 [Classification]
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(non-insulin-dependent) diabetes"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0011860:Non-Insulin Dependent Diabetes [Disease or Syndrome]
   923   C0011854:Insulin Dependent Diabetes [Disease or Syndrome]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1518422:Non [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "the most frequent form of diabetes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "it"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "5% of the population"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0032659:Population [Quantitative Concept]
   770   C0439084:>5 [Quantitative Concept]
   770   C0728893:+5 [Quantitative Concept]
   770   C1257890:Population [Population Group]

Phrase: "in Western countries"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454664:Countries [Geographic Area]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: The association between type 2 diabetes and micro- and macrovascular complications, such as premature atherosclerosis, nephropathy, retinopathy, and neuropathy, has vast public implications. 

Phrase: "The association between type 2 diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C3645563:Association type [Intellectual Product]
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "micro-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085672:MICRO [Laboratory Procedure]
  1000   C1553035:Micro [Quantitative Concept]

Phrase: "and"

Phrase: "macrovascular complications,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009566:Complications [Pathologic Function]
   861   C1171258:complications [Pathologic Function]
   827 E C2362589:Complication [Idea or Concept]
   777 E C0231242:Complicated [Functional Concept]

Phrase: "such as premature atherosclerosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0004153:Atherosclerosis [Disease or Syndrome]
   789 E C0333482:Atherosclerotic [Functional Concept]

Phrase: "nephropathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "retinopathy,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035309:Retinopathy [Disease or Syndrome]
  1000   C1962966:Retinopathy [Finding]

Phrase: "and"

Phrase: "neuropathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "has"

Phrase: "vast public implications."
Processing 00000000.tx.14: Consequently, intensive investigation into the causes of the disease to prevent its onset and optimize treatment after its diagnosis is required. 

Phrase: "Consequently,"

Phrase: "intensive investigation into the causes of the disease to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1261322:Investigation [Health Care Activity]
   742   C1552578:investigation [Idea or Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "its onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "optimize"

Phrase: "treatment after its diagnosis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "is"

Phrase: "required."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]
Processing 00000000.tx.15: Insulin resistance and impaired pancreatic -cell function are pathogenetic hallmarks of type 2 diabetes (24). 

Phrase: "Insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "impaired pancreatic -cell function"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   875   C0232786:Pancreatic function [Organ or Tissue Function]
   861   C0007613:Cell Function [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1705273:Function [Intellectual Product]
   812   C1948049:Cell [Spatial Concept]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "are"

Phrase: "pathogenetic hallmarks of type 2 diabetes"

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.16: Insulin resistance is often believed to precede the development of glucose intolerance and in the early stages is associated with enhanced -cell function that attempts to compensate for the reduced insulin sensitivity. 

Phrase: "Insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "precede"

Phrase: "the development of glucose intolerance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "and in the early stages"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C2363430:early stages [Temporal Concept]
   790 E C1517886:Early Stage [Classification]
   760   C1279919:Early [Temporal Concept]
   760   C1306673:Stages [Qualitative Concept]
   760   C1515981:And [Idea or Concept]
   726 E C0205390:Stage [Temporal Concept]
   726 E C1300072:Stage [Clinical Attribute]

Phrase: "is"

Phrase: "associated with enhanced -cell function"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   806   C0007613:Cell Function [Cell Function]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C0699040:cell associated [Cell Component]
   797   C1292719:Associated function [Functional Concept]
   760   C0007634:Cell [Cell]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1705273:Function [Intellectual Product]
   760   C1948049:Cell [Spatial Concept]
   760   C2349975:Enhanced [Activity]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "that"

Phrase: "attempts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compensate for the reduced insulin sensitivity."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0920563:Insulin Sensitivity [Pathologic Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0205432:compensate [Qualitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0392756:Reduced [Qualitative Concept]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]
Processing 00000000.tx.17: As soon as insulin secretion becomes insufficient to meet the enhanced demand, diagnostic hyperglycemia develops. 

Phrase: "As soon"

Phrase: "as insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "becomes"

Phrase: "insufficient to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205412:Insufficient [Qualitative Concept]
   861   C0231180:Insufficient [Qualitative Concept]
   789 E C0231179:Insufficiency [Functional Concept]

Phrase: "meet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550543:Meet [Idea or Concept]

Phrase: "the enhanced demand,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441516:Demand [Therapeutic or Preventive Procedure]
   861   C0699784:demand [Idea or Concept]

Phrase: "diagnostic hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "develops."
Processing 00000000.tx.18: The progressive loss of insulin secretion is affected by a metabolic milieu (gluco- and lipotoxicity) acting upon a predisposing background. 

Phrase: "The progressive loss of insulin secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "is"

Phrase: "affected by a metabolic milieu"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0311400:Metabolic [Functional Concept]
   760   C0392760:Affected [Functional Concept]
   760   C1314939:Affected [Functional Concept]
   760   C1524026:Metabolic [Cell Function]
   760   C2707259:Metabolic [Clinical Attribute]
   726 E C0001721:Affect [Mental Process]

Phrase: "(gluco-"

Phrase: "and"

Phrase: "lipotoxicity"

Phrase: ")"

Phrase: "acting upon a predisposing background."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0231203:predisposing [Functional Concept]
   760   C1706907:Background [Conceptual Entity]
   726   C0079613:ACT [Therapeutic or Preventive Procedure]
Processing 00000000.tx.19: The predisposing condition is likely to result from the polygenic interactions of several simultaneously inherited gene mutations. 

Phrase: "The predisposing condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0012634:condition [Disease or Syndrome]
   861   C0348080:Condition [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "result from the polygenic interactions of several simultaneously inherited gene mutations."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   756   C0596611:gene mutations [Genetic Function]
   738   C0017337:Gene [Gene or Genome]
   738   C0026882:Mutations [Genetic Function]
   738   C0439660:Inherited [Functional Concept]
   738   C0521115:simultaneously [Temporal Concept]
   738   C1274040:Result [Functional Concept]
   738   C1546471:Result [Idea or Concept]
   738   C2825142:Result [Finding]
   737   C0596610:gene interaction [Genetic Function]
   704   C1704675:Interaction [Functional Concept]
   704 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.20: To date, although some rare subtypes of type 2 diabetes have been described that are caused by mutations in genes encoding for crucial molecules involved in -cell development and function (i.e., glucokinase, hepatocyte nuclear factor 1 and 4, insulin promoter factor 1, insulin, and mitochondrial DNA) (4), the genetic basis of the common forms of type 2 diabetes has not yet been identified. 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "although"

Phrase: "some rare subtypes of type 2 diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449560:subtypes [Classification]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "that"

Phrase: "are"

Phrase: "caused by mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0026882:Mutations [Genetic Function]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "encoding for crucial molecules"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0567416:molecules [Substance]
   770   C1547699:Encoding [Idea or Concept]
   770   C2700640:Encoding [Activity]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in -cell development"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0815089:cell development [Cell Function]
   827   C0243107:development [Physiologic Function]
   827   C0678723:Development [Organism Function]
   827   C1527148:Development [Functional Concept]
   755 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "(i.e., glucokinase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415014:GLUCOKINASE [Gene or Genome]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "hepatocyte nuclear factor 1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   923   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "4,"

Phrase: "insulin promoter factor 1,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0248419:insulin promoter factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826562:INSULIN PROMOTER FACTOR 1 [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C2827422:Factor [Conceptual Entity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "mitochondrial DNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: ")"

Phrase: "(4"

Phrase: ")"

Phrase: ","

Phrase: "the genetic basis of the common forms of type 2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1527178:Basis [Functional Concept]
   738   C1874451:Basis [Pharmacologic Substance]

Phrase: "has"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.21: Almost a decade ago, Almind et al. 

Phrase: "Almost"

Phrase: "a decade ago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2981279:Decade [Quantitative Concept]

Phrase: "Almind et al."
Processing 00000000.tx.22: (5) reported an association between the insulin receptor substrate 1 (IRS-1) polymorphism causing a Gly-to-Arg substitution at codon 972 (Arg972 IRS-1) and type 2 diabetes. 

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "an association between the insulin receptor substrate 1 (IRS-1) polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004083:Association [Mental Process]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "a Gly-to-Arg substitution at codon 972"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1555721:Substitution [Idea or Concept]
   744   C1706204:Substitution [Activity]

Phrase: "(Arg972 IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   937   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   840   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   840   C1334133:INSULIN RECEPTOR [Gene or Genome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1710236:Substrate [Manufactured Object]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.23: IRS-1 is a major substrate for the insulin receptor and is present in tissues that are involved in glucose production, glucose clearance, and insulin secretion (6,7). 

Phrase: "IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "a major substrate for the insulin receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "is"

Phrase: "present in tissues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "that"

Phrase: "are"

Phrase: "involved in glucose production,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0033268:production [Occupational Activity]
   770   C1314939:Involved [Functional Concept]

Phrase: "glucose clearance,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272933:Glucose Clearance [Laboratory Procedure]
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.24: It acts as a multisite docking protein that binds signal proteins and links the receptor kinase to a number of cellular functions that are regulated by insulin. 

Phrase: "It"

Phrase: "acts as a multisite docking protein"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C1420414:DOCKING PROTEIN [Gene or Genome]
   790   C1760028:docking protein [Molecular Function]
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C0442632:docking [Manufactured Object]
   753   C1522290:Docking [Molecular Function]
   719 E C0330386:Dock [Plant]

Phrase: "that"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "signal proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "links"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "the receptor kinase to a number of cellular functions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "are"

Phrase: "regulated by insulin."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.25: For these reasons, the IRS-1 gene has been considered a candidate gene for common forms of type 2 diabetes. 

Phrase: "For these reasons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392360:reasons [Idea or Concept]

Phrase: "the IRS-1 gene"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1334140:Insulin Receptor Substrate 1 Gene [Gene or Genome]
           INSULIN RECEPTOR SUBSTRATE 1
   911   C1334133:Insulin Receptor Gene [Gene or Genome]
   897   C1337112:Insulin Gene [Gene or Genome]
   875   C1335671:Receptor Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   771   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "a candidate gene for common forms of type 2 diabetes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1332838:Candidate Gene [Gene or Genome]
   757   C0079429:A Gene [Gene or Genome]
   757   C0314611:Gene type [Genetic Function]
   739   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.26: Indeed, after the above-mentioned study (5), several investigations have been performed, usually suggesting that the Arg972 IRS-1 polymorphism could predispose individuals to type 2 diabetes (812). 

Phrase: "Indeed,"

Phrase: "after"

Phrase: "the above-mentioned study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "several investigations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261322:Investigations [Health Care Activity]
   827 E C1552578:investigation [Idea or Concept]
   777 E C1517586:Investigational [Qualitative Concept]
   777 E C3245491:investigational [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: ","

Phrase: "usually"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the Arg972 IRS-1 polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0032529:Polymorphism [Genetic Function]
   799   C1882417:Polymorphism [Qualitative Concept]
   734   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "could"

Phrase: "predispose"

Phrase: "individuals to type 2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0027361:Individual [Population Group]
   726   C0237401:Individual [Human]

Phrase: "(812"

Phrase: ")."
Processing 00000000.tx.27: A greater degree of insulin resistance in type 2 diabetic patients carrying the Arg972 IRS-1 polymorphism has been observed in some (13,14), but not all, investigations (15,16). 

Phrase: "A greater degree of insulin resistance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0441889:Degree [Qualitative Concept]
   753   C0449286:Degree [Quantitative Concept]
   753   C0542560:Degree [Intellectual Product]
   753   C1561545:degree [Quantitative Concept]
   753   C2348088:Degree [Quantitative Concept]

Phrase: "in type 2 diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the Arg972 IRS-1 polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0032529:Polymorphism [Genetic Function]
   799   C1882417:Polymorphism [Qualitative Concept]
   734   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "observed in some"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "(13,"

Phrase: "14"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all,"

Phrase: "investigations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1261322:Investigations [Health Care Activity]
   966 E C1552578:investigation [Idea or Concept]
   916 E C1517586:Investigational [Qualitative Concept]
   916 E C3245491:investigational [Intellectual Product]

Phrase: "(15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.28: Interestingly, type 2 diabetic patients as well as their nondiabetic nonobese first-degree relatives carrying the Arg972 IRS-1 polymorphism have lower fasting plasma insulin levels and lower insulin responses to glucose than noncarriers (17,18). 

Phrase: "Interestingly,"

Phrase: "type 2 diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "as well as"

Phrase: "their nondiabetic nonobese first-degree relatives"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   884   C1518469:First Degree Relatives [Quantitative Concept]
   851 E C1517194:First Degree Relative [Family Group]
   840   C0444502:First degree [Qualitative Concept]
   804   C0080103:Relatives [Family Group]
   804   C0205435:First [Quantitative Concept]
   804   C0441889:Degree [Qualitative Concept]
   804   C0449286:Degree [Quantitative Concept]
   804   C0542560:Degree [Intellectual Product]
   804   C1279901:First [Qualitative Concept]
   804   C1561545:degree [Quantitative Concept]
   804   C2348088:Degree [Quantitative Concept]
   771 E C0205345:Relative [Qualitative Concept]
   771 E C1547039:*Relative [Quantitative Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the Arg972 IRS-1 polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0032529:Polymorphism [Genetic Function]
   799   C1882417:Polymorphism [Qualitative Concept]
   734   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "have"

Phrase: "lower fasting plasma insulin levels"
Meta Candidates (Total=18; Excluded=6; Pruned=0; Remaining=12)
   851   C1276042:Plasma insulin level [Laboratory Procedure]
   840   C0202098:insulin levels [Laboratory Procedure]
   840   C0428405:insulin levels [Laboratory or Test Result]
   840   C0857690:plasma insulin [Laboratory Procedure]
   804   C0015663:Fasting [Finding]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0032105:Plasma [Body Substance]
   804   C0441889:Levels [Qualitative Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   804   C1550565:fasting [Intellectual Product]
   804   C1579433:Insulin [Pharmacologic Substance]
   771 E C0456079:Level [Classification]
   771 E C0456962:Fast [Qualitative Concept]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "lower insulin responses to glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "than noncarriers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2986416:Noncarrier [Conceptual Entity]

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.29: Lately, it has been reported that normal glucose-tolerant subjects with the polymorphism have decreased insulin secretion and normal insulin sensitivity (19), thus suggesting that the Arg972 IRS modification can indeed play a role in -cell dysfunction. 

Phrase: "Lately,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that normal glucose-tolerant subjects with the polymorphism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   711   C0681850:Subject [Group]
   711   C1550501:{Subject} [Idea or Concept]
   711   C1706203:Subject [Idea or Concept]
   711   C2349001:Subject [Human]
   711   C2697811:Subject [Functional Concept]

Phrase: "have"

Phrase: "decreased insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C1371675:Decreased Insulin Secretion [Organ or Tissue Function]
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "normal insulin sensitivity"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   901   C0858301:normal insulin [Finding]
   901   C0920563:Insulin Sensitivity [Pathologic Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036667:Sensitivity [Quantitative Concept]
   827   C0312418:Sensitivity [Mental Process]
   827   C0427965:Sensitivity [Finding]
   827   C1511883:Sensitivity [Quantitative Concept]
   827   C1522640:Sensitivity [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C2346484:SENSITIVITY [Phenomenon or Process]
   827   C2349185:Sensitivity [Qualitative Concept]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   755 E C0332324:Sensitive [Functional Concept]
   755 E C1550474:sensitive [Idea or Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(19"

Phrase: ")"

Phrase: ","

Phrase: "thus"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the Arg972 IRS modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0392747:Modification [Functional Concept]
   804   C1554963:modification [Qualitative Concept]

Phrase: "can"

Phrase: "indeed"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in -cell dysfunction."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0031847:dysfunction [Functional Concept]
   812   C0277785:Dysfunction, NOS [Qualitative Concept]
   756 E C0231174:Malfunction [Functional Concept]
   756 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.30: Defects of insulin signaling at the -cell level have been shown to contribute to impaired insulin secretion (2022). 

Phrase: "Defects of insulin signaling"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0243067:defects [Functional Concept]
   737 E C1457869:Defect [Functional Concept]
   737 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "at the -cell level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute to impaired insulin secretion"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C0221099:Impaired [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1880177:Contribute [Activity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(2022"

Phrase: ")."
Processing 00000000.tx.31: An impairment of glucose-mediated insulin secretion has been reported with disruption of the insulin receptor gene of the -cell (21), a knockout for islet IRS-1 (22), and overexpression of the Arg972 IRS-1 polymorphism in a rat insulinoma cell line (22). 

Phrase: "An impairment of glucose-mediated insulin secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0684336:Impairment [Pathologic Function]

Phrase: "has"

Phrase: "been"

Phrase: "reported with disruption of the insulin receptor gene of the -cell"
Meta Candidates (Total=22; Excluded=1; Pruned=0; Remaining=21)
   775   C1334133:Insulin Receptor Gene [Gene or Genome]
           INSULIN RECEPTOR
   756   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   756   C1335671:Receptor Gene [Gene or Genome]
   754   C0030281:Insulin Cell [Cell]
   754   C1337112:Insulin Gene [Gene or Genome]
   754   C1514760:Receptor Cell [Cell]
   754   C1861886:CELL Gene [Gene or Genome]
   738   C0007634:Cell [Cell]
   738   C0017337:Gene [Gene or Genome]
   738   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C0332453:Disruption [Functional Concept]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0684224:Reported [Intellectual Product]
   738   C0700287:Reported [Health Care Activity]
   738   C1269647:Cell [Cell]
   738   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C1579433:Insulin [Pharmacologic Substance]
   738   C1704653:Cell [Medical Device]
   738   C1948049:Cell [Spatial Concept]
   738   C3496591:Reported [Clinical Attribute]
   704 E C3273238:Report [Intellectual Product]

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "a knockout for islet IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0560617:knock out [Injury or Poisoning]
   744   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "overexpression of the Arg972 IRS-1 polymorphism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1514559:Overexpression [Genetic Function]

Phrase: "in a rat insulinoma cell line"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   923   C1514733:Rat Cell Line [Cell]
   861   C0007600:Cell Line [Cell]
   812   C0007634:Cell [Cell]
   812   C0021670:insulinoma [Neoplastic Process]
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.32: More recently, we have demonstrated that the Arg972 IRS-1 polymorphism impairs human pancreatic -cell survival and causes resistance to the anti-apoptotic effects of insulin (23). 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the Arg972 IRS-1 polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0032529:Polymorphism [Genetic Function]
   799   C1882417:Polymorphism [Qualitative Concept]
   734   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "impairs"

Phrase: "human pancreatic -cell survival"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C0427861:human cell [Laboratory or Test Result]
   861   C0007620:Cell Survival [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0038952:Survival [Activity]
   812   C0220921:survival [Functional Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "resistance to the anti-apoptotic effects of insulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0021655:Insulin Resistance [Pathologic Function]
   767   C2700570:INSULIN RESISTANCE [Gene or Genome]
   744   C0237834:Resistance [Mental Process]
   744   C1514892:Resistance [Physiologic Function]
   735   C0332325:Resistant to [Functional Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.33: Our laboratory processes pancreata of large mammals and humans on a regular basis for the preparation of isolated islets (2427). 

Phrase: "Our laboratory processes pancreata of large mammals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   714   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "humans on a regular basis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086418:Humans [Human]

Phrase: "for the preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "of isolated islets"

Phrase: "(2427"

Phrase: ")."
Processing 00000000.tx.34: We received pancreata from two nondiabetic donors (Table 1) in whom the Arg972 IRS-1 polymorphism was demonstrated; 

Phrase: "We"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "pancreata from two nondiabetic donors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   726   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "in whom"

Phrase: "the Arg972 IRS-1 polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0032529:Polymorphism [Genetic Function]
   799   C1882417:Polymorphism [Qualitative Concept]
   734   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "was"

Phrase: "demonstrated"

Phrase: ";"
Processing 00000000.tx.35: this gave us the unique opportunity to study a number of morphological and functional properties of the isolated islets and to compare the results with those obtained with the islets from two control donors (Table 1). 

Phrase: "this"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "us the unique opportunity to"

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "a number of morphological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "functional properties of the isolated islets"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the results with those"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "obtained with the islets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "from two control donors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0013018:Donors [Population Group]
   827   C1527169:Donors [Finding]
   793 E C0040288:Donor [Population Group]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.36: View this table: [in this window] [in a new window]  TABLE 1 Clinical characteristics of pancreas donors  When islet insulin content was measured, it was significantly lower in islets carrying the Arg972 IRS-1 polymorphism (94  47 U/islet; n = 33) than in wild-type islets (133  56 U/islet; n = 35; P < 0.05). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 Clinical characteristics of pancreas donors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0683325:clinical characteristics [Clinical Attribute]
   748   C1521970:Characteristics [Qualitative Concept]

Phrase: "When"

Phrase: "islet insulin content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: ","

Phrase: "it"

Phrase: "was"

Phrase: "significantly lower in islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the Arg972 IRS-1 polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0032529:Polymorphism [Genetic Function]
   799   C1882417:Polymorphism [Qualitative Concept]
   734   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "(94  47 U/islet"

Phrase: "; n = 33"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "than"

Phrase: "in wild-type islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(133  56 U/islet"

Phrase: "; n = 35"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.37: Insulin mRNA levels analyzed by semiquantitative RT-PCR were slightly, but not significantly, decreased (by 13%) in variant islets compared with wild-type islets (data not shown). 

Phrase: "Insulin mRNA levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0202098:insulin levels [Laboratory Procedure]
   913   C0428405:insulin levels [Laboratory or Test Result]
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "analyzed by semiquantitative RT-PCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0599161:RT-PCR [Molecular Biology Research Technique]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0677874:pCR [Finding]
   760   C0936012:Analyzed [Research Activity]

Phrase: "were"

Phrase: "slightly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "but"

Phrase: "not significantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "("

Phrase: "by 13%"

Phrase: ")"

Phrase: "in variant islets"

Phrase: "compared with wild-type islets"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.38: Insulin secretion results (expressed as percent of insulin content) in response to glucose, arginine, and glibenclamide are reported in Table 2. 

Phrase: "Insulin secretion results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]
   734   C1256369:insulin secretion [Cell Function]

Phrase: "("

Phrase: "expressed as percent of insulin content"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0423896:Content [Mental Process]
   753   C0439165:Percent [Quantitative Concept]
   753   C0456205:Content [Conceptual Entity]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: ")"

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "arginine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "are"

Phrase: "reported in Table 2."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0039224:Table [Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.39: Control islets showed a progressive and significant potentiation of insulin release at increasing glucose concentrations (P < 0.05 by ANOVA). 

Phrase: "Control islets"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a progressive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205329:Progressive [Functional Concept]

Phrase: "and"

Phrase: "significant potentiation of insulin release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0279023:Potentiation [Therapeutic or Preventive Procedure]

Phrase: "at increasing glucose concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   884   C0427743:Glucose concentration [Laboratory Procedure]
   884   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(P < 0.05 by ANOVA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.40: Conversely, the Arg972 IRS-1 islets had lower insulin secretion, with no significant increase in response to the stepwise increase of glucose levels in the medium. 

Phrase: "Conversely,"

Phrase: "the Arg972 IRS-1 islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "had"

Phrase: "lower insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "with no significant increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to the stepwise increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "of glucose levels"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0428548:glucose levels [Laboratory or Test Result]
   966 E C0337438:glucose level [Laboratory Procedure]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the medium."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]
Processing 00000000.tx.41: The Arg972 IRS-1 islets also showed a relatively lower insulin release in response to glibenclamide and a higher secretion of the hormone in response to arginine than control islets (Table 2). 

Phrase: "The Arg972 IRS-1 islets also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   710   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a relatively lower insulin release in response"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "to glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "a higher secretion of the hormone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0312431:Hormone secretion [Organ or Tissue Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to arginine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "than control islets"

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.42: View this table: [in this window] [in a new window]  TABLE 2 Insulin release from control and Gly972 Arg IRS-1 islets in response to different stimuli  Table 3 illustrates proinsulin secretion. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 2 Insulin release from control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Gly972 Arg IRS-1 islets in response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   745   C1416480:ISLET 1 [Gene or Genome]

Phrase: "to different stimuli  Table 3"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0039224:Table [Manufactured Object]
   812   C0234402:Stimuli [Phenomenon or Process]
   812   C1705242:Different [Qualitative Concept]
   812   C1706073:Table [Medical Device]
   812   C1706074:Table [Intellectual Product]
   741 E C1705241:*Difference [Quantitative Concept]
   712 E C0443199:Differential [Qualitative Concept]

Phrase: "illustrates"

Phrase: "proinsulin secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
Processing 00000000.tx.43: Similar to insulin release, proinsulin secretion from Arg972 IRS-1 islets showed no significant increase in response to glucose. 

Phrase: "Similar to insulin release,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "proinsulin secretion from Arg972 IRS-1 islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1256369:insulin secretion [Cell Function]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no significant increase in response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "to glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.44: When the insulin-to-proinsulin molar ratio was calculated, no significant difference was found between wild-type and polymorphic islets when the cells were challenged with glucose or glibenclamide (data not shown). 

Phrase: "When"

Phrase: "the insulin-to-proinsulin molar ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C2825550:Molar Ratio [Quantitative Concept]
   804   C0456603:Ratio [Quantitative Concept]
   804   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: ","

Phrase: "no significant difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "found between wild-type"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0150312:Found [Quantitative Concept]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "polymorphic islets"

Phrase: "when"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "challenged with glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   756   C0798503:Challenge [Clinical Attribute]
   756   C0805586:Challenge [Health Care Activity]
   756   C3274764:Challenge [Conceptual Entity]

Phrase: "or"

Phrase: "glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.45: However, a lower ratio was apparent for Arg972 IRS-1 than for control islets in response to arginine (4.4  2.1 vs. 7.9  2.9; P < 0.05). 

Phrase: "However,"

Phrase: "a lower ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "apparent for Arg972 IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0750489:apparent [Idea or Concept]

Phrase: "than"

Phrase: "for control islets"

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to arginine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(4.4  2.1"

Phrase: "vs. 7.9  2.9"

Phrase: "; P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.46: View this table: [in this window] [in a new window]  TABLE 3 Proinsulin secretion results from control and Gly972Arg islets in response to different stimuli  Glucose utilization and oxidation increased as a function of the increasing glucose concentration, both in control and Arg972 IRS-1 islets, with no difference between wild-type and variant islets (Table 4). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 3 Proinsulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]

Phrase: "results from control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0243148:control [Qualitative Concept]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C2825142:Result [Finding]
   790   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "Gly972Arg islets in response"

Phrase: "to different stimuli  Glucose utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0042153:utilization [Functional Concept]

Phrase: "and"

Phrase: "oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "increased as a function of the increasing glucose concentration,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   764   C0427743:Glucose concentration [Laboratory Procedure]
   764   C1287281:Glucose concentration [Laboratory or Test Result]
   762   C0086045:Concentration, function [Mental Process]
           Concentration
   762   C0860803:glucose increased [Finding]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0031843:function [Physiologic Function]
   742   C0205217:Increased [Quantitative Concept]
   742   C0442805:Increased [Functional Concept]
   742   C0542341:Function [Functional Concept]
   742   C0700205:FUNCTION [Classification]
   742   C1446561:Concentration [Quantitative Concept]
   742   C1705273:Function [Intellectual Product]

Phrase: "both in control"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0238767:Both [Spatial Concept]
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1706086:Both [Qualitative Concept]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "Arg972 IRS-1 islets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "with no difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "between wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "variant islets"

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.47: View this table: [in this window] [in a new window]  TABLE 4 Glucose utilization and oxidation in islets isolated from subjects carrying the Gly972Arg IRS-1 polymorphism and in control islets  By electron microscopy, it was shown that the percent of -cells was similar in control islets (61  3%) as in Arg972 IRS-1 islets (63  2%). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 4 Glucose utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0042153:utilization [Functional Concept]

Phrase: "and"

Phrase: "oxidation in islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030011:Oxidation [Molecular Function]

Phrase: "isolated from subjects"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756 E C1875400:ISOLATE [Pharmacologic Substance]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the Gly972Arg IRS-1 polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0032529:Polymorphism [Genetic Function]
   799   C1882417:Polymorphism [Qualitative Concept]
   734   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "and in control islets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "By electron microscopy,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0026019:Electron Microscopy [Laboratory Procedure]
  1000   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   861   C0013852:Electron [Quantitative Concept]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C3463986:Electron [Bird]
   789 E C0013850:Electronic [Manufactured Object]
   789 E C0205288:Microscopic [Qualitative Concept]
   789 E C1547561:Electronic [Idea or Concept]

Phrase: "it"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the percent of -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "similar in control islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "(61  3%"

Phrase: ")"

Phrase: "as in Arg972 IRS-1 islets"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   770   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   770   C1334133:INSULIN RECEPTOR [Gene or Genome]
   750   C1416480:ISLET 1 [Gene or Genome]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1710236:Substrate [Manufactured Object]

Phrase: "(63  2%"

Phrase: ")."
Processing 00000000.tx.48: In addition, the amount of -cells did not differ significantly between wild-type (22  4%) and variant (16  3%) islets. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the amount of -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ"

Phrase: "significantly between wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "(22  4%"

Phrase: ")"

Phrase: "and"

Phrase: "variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:Variant [Qualitative Concept]

Phrase: "(16  3%"

Phrase: ")"

Phrase: "islets."
Processing 00000000.tx.49: Quantification of -cell secretory granules indicated a greater number of immature and a severalfold lower amount of mature secretory granules in the Arg972 IRS-1 islets compared to control islets (Fig. 1 and Table 5). 

Phrase: "Quantification of -cell secretory granules"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   840   C0886515:Secretory Granules [Cell Component]
   836   C0010837:Cell granule [Cell Component]
           Granules
   806 E C3271154:Secretory Granule [Cell Component]
   804   C0993609:Granules [Biomedical or Dental Material]
   804   C1327616:Secretory [Cell Function]
   721 E C0205248:Granular [Qualitative Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "a greater number of immature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "a severalfold lower amount of mature secretory granules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:Amount [Quantitative Concept]

Phrase: "in the Arg972 IRS-1 islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "islets"

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "Table 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.50: View larger version (164K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(164K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.51: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.52: Electron microscopy of control (upper) and Gly972Arg IRS-1 (lower) islets, showing a greater number of more immature granules in the latter.  

Phrase: "Electron microscopy of control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0026019:Electron Microscopy [Laboratory Procedure]
   833   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   770   C0013852:Electron [Quantitative Concept]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C3463986:Electron [Bird]

Phrase: "(upper"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282910:Upper [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Gly972Arg IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   937   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   840   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   840   C1334133:INSULIN RECEPTOR [Gene or Genome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1710236:Substrate [Manufactured Object]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: ")"

Phrase: "islets,"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a greater number of more immature granules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "in the latter."
Processing 00000000.tx.53: View this table: [in this window] [in a new window]  TABLE 5 Volume density and number of immature and mature secretory granules in beta-cells from control and Gly972Arg IRS-1 islets  Type 2 diabetes is a dual-disorder condition, characterized by insulin resistance and impaired insulin secretion. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 5 Volume density"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0178587:density [Quantitative Concept]
   812   C0449468:*Volume [Quantitative Concept]
   812   C1690016:% volume [Qualitative Concept]
   812   C1705102:Volume [Intellectual Product]
   812   C2700258:Volume [Laboratory Procedure]
   741 E C0439794:Dense [Qualitative Concept]

Phrase: "and"

Phrase: "number of immature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0237753:*Number [Quantitative Concept]
   790   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "mature secretory granules in beta-cells"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0886515:Secretory Granules [Cell Component]
   767   C1519221:Secretory cell [Cell]
   756 E C3271154:Secretory Granule [Cell Component]
   753   C0010837:Granules [Cell Component]
           Cell granule
   753   C0205286:Mature [Temporal Concept]
   753   C0993609:Granules [Biomedical or Dental Material]
   753   C1327616:Secretory [Cell Function]
   750   C0596630:granule cell [Cell]

Phrase: "from control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "Gly972Arg IRS-1 islets  Type 2 diabetes"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   877   C0381451:Insulin Receptor Substrate-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   877   C1334141:INSULIN RECEPTOR SUBSTRATE 2 [Gene or Genome]
   877   C1334191:Insulin Receptor Substrate 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   854   C0457592:Insulin type [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0011860:Type 2 Diabetes [Disease or Syndrome]
   817   C1320657:type diabetes [Finding]
   807   C0441730:Type 2 [Classification]
   800   C1425576:ISLET 2 [Gene or Genome]
   791   C0011847:Diabetes [Disease or Syndrome]
   791   C0011849:Diabetes [Disease or Syndrome]
   791   C0332307:Type [Qualitative Concept]
   791   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "a dual-disorder condition,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   755 E C0009647:Conditioned [Mental Process]
   755 E C1701901:Conditional [Qualitative Concept]
   755 E C1963686:Conditional [Functional Concept]
   727 E C1519605:Conditionality [Conceptual Entity]

Phrase: "characterized by insulin resistance"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1880022:Characterized [Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "impaired insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.54: Although type 2 diabetes is likely to reflect a polygenic background to account for the defect of peripheral insulin action and reduced -cell response to glucose, recent studies have pointed out that a common defect may be shared by the -cell and the insulin-target cell. 

Phrase: "Although"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "a polygenic background to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706907:Background [Conceptual Entity]

Phrase: "account for the defect of peripheral insulin action"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0205100:Peripheral [Spatial Concept]
   744   C0441472:Action [Functional Concept]
   744   C1457869:Defect [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1551359:account [Idea or Concept]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1861101:DEFECT [Disease or Syndrome]
   744   C2741673:Account # [Clinical Attribute]
   744   C2981730:Account [Classification]
   744   C3266814:Action [Activity]

Phrase: "and"

Phrase: "reduced -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "cell response to glucose,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "pointed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552961:Point [Quantitative Concept]
   966   C2347617:point [Quantitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "that"

Phrase: "a common defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1457869:Defect [Functional Concept]
   861   C1861101:DEFECT [Disease or Syndrome]

Phrase: "may"

Phrase: "be"

Phrase: "shared by the -cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007634:Cell [Cell]
   770   C0237876:shared [Social Behavior]
   770   C1269647:Cell [Cell]
   770   C1522138:Shared [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the insulin-target cell."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   913   C0030281:Insulin Cell [Cell]
   901   C0221284:Target cell [Cell]
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1521840:Target [Functional Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.55: This hypothesis is supported by the observation that alteration of the insulin receptor or disruption of the insulin signaling pathway may result in both insulin resistance and reduced -cell function (35). 

Phrase: "This hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "supported by the observation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1521721:Supported [Conceptual Entity]
   770   C1964257:Observation [Diagnostic Procedure]
   737 E C0183683:Support [Medical Device]

Phrase: "that alteration of the insulin receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515926:Alteration [Idea or Concept]

Phrase: "or"

Phrase: "disruption of the insulin signaling pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332453:Disruption [Functional Concept]

Phrase: "may"

Phrase: "result in both insulin resistance"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0021655:Insulin Resistance [Pathologic Function]
   806   C2700570:INSULIN RESISTANCE [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0237834:Resistance [Mental Process]
   760   C1274040:Result [Functional Concept]
   760   C1514892:Resistance [Physiologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1546471:Result [Idea or Concept]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2825142:Result [Finding]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "reduced -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "cell function"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0007613:Cell Function [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1705273:Function [Intellectual Product]
   861   C1948049:Cell [Spatial Concept]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.56: In the present study, we showed for the first time that human pancreatic islets from carriers of the Gly972Arg amino acid polymorphism in IRS-1 have reduced insulin content, altered insulin release, and greater number of immature secretory granules. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "showed for the first time"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0040223:Time [Temporal Concept]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   726   C1547282:Show [Intellectual Product]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "that human pancreatic islets from carriers of the Gly972Arg amino acid polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   736   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "in IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "have"

Phrase: "reduced insulin content,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "altered insulin release,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "greater number of immature secretory granules."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.57: Because no major difference was seen in the percent of -cells in control and variant islets, it is suggested that these alterations are mainly attributable to functional abnormalities of the insulin-secreting cells. 

Phrase: "Because"

Phrase: "no major difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "seen in the percent of -cells"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C0205397:Seen [Qualitative Concept]
   753   C0439165:Percent [Quantitative Concept]
   753   C3282337:Cells [Cell]
   719 E C0042789:see [Organism Function]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1947903:See [Activity]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "variant islets,"

Phrase: "it"

Phrase: "is"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515926:Alteration [Idea or Concept]

Phrase: "are"

Phrase: "mainly attributable to functional abnormalities of the insulin-secreting cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0596130:Attributable [Mental Process]
Processing 00000000.tx.58: This might be caused by several factors, but the present experimental evidence supports the primary role of the Gly972Arg amino acid polymorphism in IRS-1. 

Phrase: "This"

Phrase: "might"

Phrase: "be"

Phrase: "caused by several factors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0015127:cause [Functional Concept]
   737   C1521761:Factor [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "but"

Phrase: "the present experimental evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332120:Evidence [Functional Concept]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the primary role of the Gly972Arg amino acid polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "in IRS-1."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.59: In fact, the insulin signaling involving the IRS-1/phosphatidylinositol (PI) 3-kinase pathway has been shown to play an important role in insulin secretion by regulating the mobilization of intracellular Ca2+ stores (28). 

Phrase: "In fact,"

Phrase: "the insulin signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "the IRS-1/phosphatidylinositol (PI) 3-kinase pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   892   C2984427:Insulin Pathway [Functional Concept]
   793   C1704259:Pathway [Molecular Function]
   793   C1705987:Pathway [Conceptual Entity]
   711   C2350410:Insulin Receptor Substrate-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "by"

Phrase: "regulating"

Phrase: "the mobilization of intracellular Ca2+ stores"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   753   C0300926:mobilization [Functional Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.60: Moreover, in experimental rodent models, the IRS-1/PI 3-kinase system is altered in -cells carrying the Arg972 IRS-1 polymorphism (22,23). 

Phrase: "Moreover,"

Phrase: "in experimental rodent models,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0086272:Models, Experimental [Intellectual Product]
   827   C3161035:Models [Intellectual Product]

Phrase: "the IRS-1/PI 3-kinase system"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   721 E C0205373:Systemic [Functional Concept]
   711   C2350410:Insulin Receptor Substrate-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the Arg972 IRS-1 polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0032529:Polymorphism [Genetic Function]
   799   C1882417:Polymorphism [Qualitative Concept]
   734   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.61: The integrity of the insulin-signaling pathways is conceived as essential for normal insulin action and in particular for insulin-mediated glucose transport and metabolism. 

Phrase: "The integrity of the insulin-signaling pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205266:integrity [Qualitative Concept]
   748   C0872403:integrity [Individual Behavior]
   748   C1947912:Integrity [Qualitative Concept]

Phrase: "is"

Phrase: "conceived as essential"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205224:Essential [Qualitative Concept]
   790   C0232908:Conceived [Functional Concept]

Phrase: "for normal insulin action"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0858301:normal insulin [Finding]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0441472:Action [Functional Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C3266814:Action [Activity]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and in particular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "for insulin-mediated glucose transport"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2984428:Insulin-mediated glucose transport [Functional Concept]
   861   C0178666:glucose transport [Cell Function]
   812   C0005528:Transport, NOS [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C1317949:Transport [Manufactured Object]
   812   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.62: In our study, however, the Gly972Arg amino acid polymorphism was not associated with any detectable defect in glucose utilization and/or oxidation. 

Phrase: "In our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "however,"

Phrase: "the Gly972Arg amino acid polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with any detectable defect"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in glucose utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042153:utilization [Functional Concept]

Phrase: "and/or"

Phrase: "oxidation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.63: It should be recalled that the IRS-1/PI 3-kinase system is more involved in GLUT4 translocation in insulin-target tissues, whereas -cells express the GLUT2 transporter. 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "recalled"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0034770:Recall [Mental Process]
   966   C1705180:Recall [Governmental or Regulatory Activity]
   966   C2361119:Recall [Clinical Attribute]

Phrase: "that"

Phrase: "the IRS-1/PI 3-kinase system"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   721 E C0205373:Systemic [Functional Concept]
   711   C2350410:Insulin Receptor Substrate-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "involved in GLUT4 translocation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0040715:Translocation [Cell or Molecular Dysfunction]
   770   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1314939:Involved [Functional Concept]
   770   C1420175:GLUT4 [Gene or Genome]
   770   C2982484:GLUT4 [Gene or Genome]
   770   C2987521:Translocation [Activity]

Phrase: "in insulin-target tissues,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0040300:Tissues [Tissue]
   827   C1521840:Target [Functional Concept]
   827   C2986546:TARGET [Diagnostic Procedure]
   793 E C1547928:Tissue [Intellectual Product]

Phrase: "whereas -"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "the GLUT2 transporter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.64: At variance with the impaired insulin response to glucose, islets expressing the Gly972Arg amino acid polymorphism for IRS-1 exhibited a larger insulin release when challenged with arginine as compared to wild-type -cells. 

Phrase: "At variance with the impaired insulin response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "to glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "islets"

Phrase: "expressing"

Phrase: "the Gly972Arg amino acid polymorphism for IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0032529:Polymorphism [Genetic Function]
   739   C1882417:Polymorphism [Qualitative Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a larger insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "when"

Phrase: "challenged with arginine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756   C0798503:Challenge [Clinical Attribute]
   756   C0805586:Challenge [Health Care Activity]
   756   C3274764:Challenge [Conceptual Entity]

Phrase: "as"

Phrase: "compared to wild-type -cells."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   806   C1883559:Wild Type [Organism Attribute]
   797   C0449475:cells type [Intellectual Product]
   781 E C0007634:Cell Type [Cell]
           Cells
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.65: Arginine can stimulate insulin through various mechanisms, including depolarization of the -cell membrane because of its transport in a positively charged form (29), by production of nitric oxide (30), and, indirectly, by stimulation of glucagon secretion from -cells (31). 

Phrase: "Arginine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "can"

Phrase: "stimulate"

Phrase: "insulin through various mechanisms,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "depolarization of the -cell membrane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C1816453:membrane depolarization [Cell Function]

Phrase: "because of its transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]

Phrase: "in a positively charged form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "by production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "of nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: ","

Phrase: "indirectly,"

Phrase: "by stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "of glucagon secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2610739:glucagon secretion [Cell Function]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "from -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.66: Although drawing conclusions in this regard is beyond the purpose of our study, it may be of interest that we did not find any evident change in the percent of -cells between control and Arg972 IRS-1 islets. 

Phrase: "Although"

Phrase: "drawing conclusions in this regard"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707478:Conclusions [Idea or Concept]

Phrase: "is beyond the purpose of our study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0681832:purpose of study [Research Activity]
   748   C0557651:Study [Manufactured Object]
   748   C1285529:Purpose [Functional Concept]
   748   C2603343:Study [Research Activity]

Phrase: "it"

Phrase: "may"

Phrase: "be of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C2987476:Be [Conceptual Entity]

Phrase: "interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:Interest [Mental Process]

Phrase: "that"

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "any evident change in the percent of -cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C1705241:Change [Quantitative Concept]

Phrase: "between control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "Arg972 IRS-1 islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
Processing 00000000.tx.67: In any event, the effect of arginine on insulin secretion from Arg972 IRS-1 islets was accompanied by a relative hypersecretion of proinsulin, as suggested by the decreased insulin-to-proinsulin molar ratio, which is a feature of -cell dysfunction (32). 

Phrase: "In any event,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441471:Event [Event]

Phrase: "the effect of arginine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "from Arg972 IRS-1 islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "was"

Phrase: "accompanied by a relative hypersecretion of proinsulin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]

Phrase: "as"

Phrase: "suggested by the decreased insulin-to-proinsulin molar ratio,"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   764   C2825550:Molar Ratio [Quantitative Concept]
   762   C1718242:Proinsulin/Insulin [Quantitative Concept]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0026367:Molar [Body Part, Organ, or Organ Component]
   742   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205216:Decreased [Quantitative Concept]
   742   C0392756:Decreased [Qualitative Concept]
   742   C0442797:decreased [Qualitative Concept]
   742   C0456603:Ratio [Quantitative Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1547037:Ratio [Intellectual Product]
   742   C1579433:Insulin [Pharmacologic Substance]
   708 E C0547047:Decrease [Quantitative Concept]
   708   C1705535:Suggest [Idea or Concept]

Phrase: "which"

Phrase: "is"

Phrase: "a feature of -cell dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0031847:dysfunction [Functional Concept]
   812   C0277785:Dysfunction, NOS [Qualitative Concept]
   756 E C0231174:Malfunction [Functional Concept]
   756 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.68: Human pancreatic -cells expressing the Gly972Arg amino acid IRS-1 polymorphism showed a much larger number of immature secretory granules than control islets. 

Phrase: "Human pancreatic -cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0427861:Human cells [Laboratory or Test Result]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the Gly972Arg amino acid IRS-1 polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0032529:Polymorphism [Genetic Function]
   793   C1882417:Polymorphism [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a much larger number of immature secretory granules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]

Phrase: "than control islets."
Processing 00000000.tx.69: In this regard, there is evidence that insulin stimulates pancreatic duodenal homeobox 1 (PDX-1) DNA-binding activity and insulin promoter activity via a pathway involving PI 3-kinase (33). 

Phrase: "In this regard,"

Phrase: "there"

Phrase: "is"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "pancreatic duodenal homeobox 1 (PDX-1) DNA-binding activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C2266866:Binding Activity [Molecular Function]
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "insulin promoter activity via a pathway"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1145751:insulin activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "PI 3-kinase"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.70: More recently, it has been demonstrated that expression of PDX-1 in liver by recombinant adenovirusmediated gene transfer results in the induction of expression of prohormone convertase 1/3 (PC 1/3), a protease that converts proinsulin to mature insulin (34). 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "that expression of PDX-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "by recombinant adenovirusmediated gene transfer results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C1274040:Result [Functional Concept]
   771   C1546471:Result [Idea or Concept]
   771   C2825142:Result [Finding]

Phrase: "in the induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of prohormone convertase 1/3 (PC 1/3),"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0135615:Prohormone Convertase 1 [Amino Acid, Peptide, or Protein,Enzyme]
           Prohormone Convertase 3
   923   C1418388:PROHORMONE CONVERTASE 1 [Gene or Genome]
           PROHORMONE CONVERTASE 3
   861   C1258132:Prohormone Convertase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0301817:Prohormone [Hormone]

Phrase: "a protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Protease [Enzyme]

Phrase: "that"

Phrase: "converts"

Phrase: "proinsulin to mature insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1718242:Proinsulin/Insulin [Quantitative Concept]
   770   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.71: Although we have not directly addressed this issue, it seems possible that in the Arg972 IRS-1 -cells, the reduced insulin action might decrease PDX-1 activity, which, in turn, might reduce the expression of PC 1/3. 

Phrase: "Although"

Phrase: "we"

Phrase: "have"

Phrase: "not directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "this issue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]

Phrase: "it"

Phrase: "seems"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that in the Arg972 IRS-1 -cells,"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   818   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   764   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   764   C1334133:INSULIN RECEPTOR [Gene or Genome]
   745   C0030281:Insulin Cell [Cell]
   745   C1514760:Receptor Cell [Cell]
   742   C0007634:Cells [Cell]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1710236:Substrate [Manufactured Object]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "the reduced insulin action"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0441472:Action [Functional Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C3266814:Action [Activity]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "might"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "PDX-1 activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "which,"

Phrase: "in turn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "might"

Phrase: "reduce"

Phrase: "the expression of PC 1/3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.72: If the glucose and arginine challenges had divergent responses in terms of insulin release in Gly972Arg islets, only a slight alteration of insulin secretion was detected in response to glibenclamide. 

Phrase: "If"

Phrase: "the glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "arginine challenges"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0805586:challenges [Health Care Activity]
   827 E C0798503:Challenge [Clinical Attribute]
   827 E C3274764:Challenge [Conceptual Entity]

Phrase: "had"

Phrase: "divergent responses in terms of insulin release"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0871261:responses [Organism Attribute]
   714 E C1704632:Response [Finding]
   714 E C1706817:Response [Intellectual Product]
   714 E C2911692:Response [Mental Process]

Phrase: "in Gly972Arg islets,"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a slight alteration of insulin secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515926:Alteration [Idea or Concept]

Phrase: "was"

Phrase: "detected in response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0442726:Detected [Finding]
   790   C0871261:Response [Organism Attribute]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to glibenclamide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.73: This finding may well be in agreement with different and alternative pathways regulating insulin secretion, but it may also provide some clinical information. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "may"

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "be in agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0680240:Agreement [Social Behavior]
   790   C2987476:Be [Conceptual Entity]

Phrase: "with different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]

Phrase: "and"

Phrase: "alternative pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "regulating"

Phrase: "insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "but"

Phrase: "it"

Phrase: "may"

Phrase: "also"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "some clinical information."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C2708732:Clinical information [Clinical Attribute]
  1000   C2708733:Clinical information [Intellectual Product]
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]
Processing 00000000.tx.74: From these results it could be argued that sulfonylureas can be initially used for the treatment of type 2 diabetic patients carrying the Gly972Arg IRS-1 polymorphism. 

Phrase: "From these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "it"

Phrase: "could"

Phrase: "be"

Phrase: "argued"

Phrase: "that sulfonylureas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0038766:SULFONYLUREAS [Organic Chemical,Pharmacologic Substance]
   966 E C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "can"

Phrase: "be"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "used for the treatment of type 2 diabetic patients"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   764   C0441730:Type 2 [Classification]
   745   C1524063:Use of [Functional Concept]
   745   C1550335:Patient type [Classification]
   742   C0030705:Patients [Patient or Disabled Group]
   742   C0039798:treatment [Functional Concept]
   742   C0087111:Treatment [Therapeutic or Preventive Procedure]
   742   C0241863:DIABETIC [Finding]
   742   C0332307:Type [Qualitative Concept]
   742   C1273517:used [Finding]
   742   C1522326:Treatment [Functional Concept]
   742   C1533734:Treatment [Therapeutic or Preventive Procedure]
   742   C1547052:*Type [Quantitative Concept]
   742   C1705169:Treatment [Conceptual Entity]
   742   C3538994:TREATMENT [Research Activity]
   708 E C0042153:use [Functional Concept]
   708 E C0457083:Use [Functional Concept]
   708 E C1947944:Use [Intellectual Product]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the Gly972Arg IRS-1 polymorphism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0032529:Polymorphism [Genetic Function]
   799   C1882417:Polymorphism [Qualitative Concept]
   734   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
Processing 00000000.tx.75: Nonetheless, these individuals can be expected to fail soon, as suggested by the higher prevalence of the Gly972Arg IRS-1 polymorphism in insulin-requiring type 2 diabetic patients as compared with patients who dont require insulin (S.G., M.F., unpublished observations). 

Phrase: "Nonetheless,"

Phrase: "these individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "can"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "soon,"

Phrase: "as"

Phrase: "suggested by the higher prevalence of the Gly972Arg IRS-1 polymorphism"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   784   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   784   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   750   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   750   C1334133:INSULIN RECEPTOR [Gene or Genome]
   735   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   735   C0032529:Polymorphism [Genetic Function]
   735   C0033105:Prevalence [Quantitative Concept]
   735   C0220900:prevalence [Quantitative Concept]
   735   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   735   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   735   C1579433:Insulin [Pharmacologic Substance]
   735   C1710236:Substrate [Manufactured Object]
   735   C1882417:Polymorphism [Qualitative Concept]
   733   C1512456:High Prevalence [Quantitative Concept]
   732   C0020459:high insulin [Disease or Syndrome]
   702   C0205250:High [Qualitative Concept]
   702   C1299351:High [Qualitative Concept]
   702   C1705535:Suggest [Idea or Concept]
   702   C2700149:HIGH [Intellectual Product]

Phrase: "in insulin-requiring type 2 diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030705:Patients [Patient or Disabled Group]

Phrase: "as"

Phrase: "compared with patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1707455:Compared [Activity]

Phrase: "who dont"

Phrase: "require"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(S.G.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "M."

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "unpublished observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: ")."
Processing 00000000.tx.76: By and large, these findings point out how, in the near future, it will be of importance to investigate the molecular characterization of the pathogenetic mechanisms responsible for hyperglycemia in order to identify the most appropriate therapeutic approach for a given patient. 

Phrase: "By"

Phrase: "and"

Phrase: "large,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549177:Large [Quantitative Concept]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "out how,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]

Phrase: "in the near future,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016884:Future [Temporal Concept]

Phrase: "it"

Phrase: "will"

Phrase: "be of importance to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2987476:Be [Conceptual Entity]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the molecular characterization of the pathogenetic mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880022:Characterization [Activity]

Phrase: "responsible for hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "identify"

Phrase: "the most appropriate therapeutic approach for a given patient."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449445:Approach [Spatial Concept]
Processing 00000000.tx.77: Therefore, the presence of the Gly972Arg IRS-1 polymorphism appears to be strongly associated with a primary defect of -cell function characterized by decreased glucose-stimulated insulin secretion, lower insulin content, and a reduced number of mature secretory granules. 

Phrase: "Therefore,"

Phrase: "the presence of the Gly972Arg IRS-1 polymorphism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "strongly"

Phrase: "associated with a primary defect of -cell function"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   770   C0007613:Cell Function [Cell Function]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   767   C0699040:cell associated [Cell Component]
   767   C1292719:Associated function [Functional Concept]
   744   C0007634:Cell [Cell]
   744   C0031843:function [Physiologic Function]
   744   C0205225:Primary [Qualitative Concept]
   744   C0439631:Primary [Therapeutic or Preventive Procedure]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1269647:Cell [Cell]
   744   C1457869:Defect [Functional Concept]
   744   C1704653:Cell [Medical Device]
   744   C1705273:Function [Intellectual Product]
   744   C1861101:DEFECT [Disease or Syndrome]
   744   C1948049:Cell [Spatial Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "characterized by decreased glucose-stimulated insulin secretion,"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   804   C1371675:Decreased Insulin Secretion [Organ or Tissue Function]
   778   C0860801:decreased glucose [Finding]
   778   C1256369:insulin secretion [Cell Function]
   774 E C1704381:Glucose decreased [Finding]
   774   C1719133:Glucose/Insulin [Quantitative Concept]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1880022:Characterized [Activity]
   748   C1948023:Stimulated [Natural Phenomenon or Process]
   714 E C0547047:Decrease [Quantitative Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "insulin content,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "a reduced number of mature secretory granules."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.78: As such, this condition may represent a typical predisposing condition for future development of type 2 diabetes, since it seems unlikely that these -cells will be able to cope with any severe and/or long-lasting increased demand of insulin secretion as it occurs in the presence of a condition of insulin resistance.  

Phrase: "As"

Phrase: "such,"

Phrase: "this condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   928 E C0009647:Conditioned [Mental Process]
   928 E C1701901:Conditional [Qualitative Concept]
   928 E C1963686:Conditional [Functional Concept]
   900 E C1519605:Conditionality [Conceptual Entity]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a typical predisposing condition for future development of type 2 diabetes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0012634:condition [Disease or Syndrome]
   738   C0348080:Condition [Qualitative Concept]
   738   C1705253:Condition [Conceptual Entity]

Phrase: "since"

Phrase: "it"

Phrase: "seems"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "these -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "will"

Phrase: "be"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "cope with any severe"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0009967:cope [Individual Behavior]
   770   C0205082:Severe [Qualitative Concept]

Phrase: "and/or"

Phrase: "long-lasting increased demand of insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441516:Demand [Therapeutic or Preventive Procedure]
   748   C0699784:demand [Idea or Concept]

Phrase: "as"

Phrase: "it"

Phrase: "occurs in the presence of a condition of insulin resistance."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   760   C0021655:Insulin Resistance [Pathologic Function]
   760   C2700570:INSULIN RESISTANCE [Gene or Genome]
   739   C0012634:condition [Disease or Syndrome]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0237834:Resistance [Mental Process]
   739   C0348080:Condition [Qualitative Concept]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C1514892:Resistance [Physiologic Function]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1705253:Condition [Conceptual Entity]
   739   C1709305:Occur [Activity]
   739   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.79: RESEARCH DESIGN AND METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS REFERENCES  The pancreata were procured through the local organ procurement agency, within the framework of a project aimed at clinical islet allotransplantation into diabetic patients and approved by the ethics committee of the University of Pisa. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   876   C0086912:methods research [Research Activity]
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The pancreata"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   966   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "procured through the local organ procurement agency,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0029210:Organ Procurement [Health Care Activity]
   748   C0178784:Organ [Body Part, Organ, or Organ Component]
   748   C0205276:Local [Spatial Concept]
   748   C0237463:Agency [Organization]
   748   C1709695:Procurement [Governmental or Regulatory Activity]
   714   C3274540:Procure [Immunologic Factor,Pharmacologic Substance]

Phrase: "within the framework"

Phrase: "of a project"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709701:Project [Conceptual Entity]

Phrase: "aimed at clinical islet allotransplantation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205210:Clinical [Qualitative Concept]
   726   C1947946:Aim [Idea or Concept]
   726   C2948600:Aim [Pharmacologic Substance]
   726   C3540471:AIM [Gene or Genome]
   726   C3540472:AIM [Functional Concept]

Phrase: "into diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "approved by the ethics committee of the University of Pisa."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0085546:Ethics Committee [Professional or Occupational Group]
   739   C0015000:Ethics [Idea or Concept]
   739   C0041740:University [Manufactured Object,Organization]
   739   C0205540:Approved [Qualitative Concept]
   739   C1527243:ethics [Idea or Concept]
   739   C2699414:Committee [Group]
Processing 00000000.tx.80: The presence of the polymorphism was detected by nested RT-PCR, as previously described (23). 

Phrase: "The presence of the polymorphism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "detected by nested RT-PCR,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0599161:RT-PCR [Molecular Biology Research Technique]
   797   C0242574:Nested PCR [Molecular Biology Research Technique]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0442726:Detected [Finding]
   760   C0677874:pCR [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.81: Procedures for islet preparation have also been reported in detail previously (2427). 

Phrase: "Procedures for islet preparation"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   856   C0548441:Preparation for procedure [Health Care Activity]
           preparation procedures
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "reported in detail previously"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1522508:Detail [Qualitative Concept]
   770   C1561567:detail [Functional Concept]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(2427"

Phrase: ")."
Processing 00000000.tx.82: Briefly, the enzyme collagenase (collagenase P; Roche Diagnostics) was used for digestion of the gland. 

Phrase: "Briefly,"

Phrase: "the enzyme collagenase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(collagenase P"

Phrase: "; Roche Diagnostics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011900:Diagnostic [Finding]
   827   C0348026:Diagnostic [Functional Concept]

Phrase: ")"

Phrase: "was"

Phrase: "used for digestion of the gland."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   767   C1524063:Use of [Functional Concept]
   753   C0012238:Digestion [Organism Function]
   753   C1273517:used [Finding]
   753   C1285092:Gland [Body Part, Organ, or Organ Component]
   753   C2349986:Digestion [Research Activity]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.83: The pancreatic duct was cannulated, and the digestion solution (collagenase, 1.52 mg/ml, dissolved in 200 ml Hanks balanced salt solution [HBSS]) was slowly injected to distend the tissue. 

Phrase: "The pancreatic duct"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0030288:Pancreatic duct [Body Part, Organ, or Organ Component]
  1000   C1269003:Pancreatic duct [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   861   C0687028:Duct [Body Part, Organ, or Organ Component]
   861   C1267211:Duct [Body Part, Organ, or Organ Component]
   861   C1550227:duct [Body Part, Organ, or Organ Component]
   861   C1705650:Duct [Medical Device]
   789 E C1512083:Ductal [Qualitative Concept]

Phrase: "was"

Phrase: "cannulated"

Phrase: ","

Phrase: "and"

Phrase: "the digestion solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(collagenase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "1.52 mg/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439294:mg ml [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "dissolved in 200 ml Hanks balanced salt solution [HBSS]"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   833   C0120742:Hanks Balanced Salt Solution [Pharmacologic Substance]
   800   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]
   754   C0598357:balance salt [Organism Function]
   744   C0036140:Salt [Chemical Viewed Structurally]
   744   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   744   C0037633:Solution [Substance]
   744   C0205415:Balanced [Functional Concept]
   744   C0206136:Salt [Food,Inorganic Chemical]
   744   C0439526:/mL [Quantitative Concept]
   744   C0525069:Solution [Biomedical or Dental Material]
   711 E C0014653:Balance [Organism Function]
   711 E C0560184:Balance [Finding]
   711   C1423529:HANK [Gene or Genome]
   711   C1549535:Dissolve [Functional Concept]

Phrase: ")"

Phrase: "was"

Phrase: "slowly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slowly [Qualitative Concept]

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "distend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700124:distend [Functional Concept]

Phrase: "the tissue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.84: After distension, the gland was placed into a 500-ml glass beaker, and the solution not used for distension was added into the beaker. 

Phrase: "After distension,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012359:Distension [Pathologic Function]

Phrase: "the gland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285092:Gland [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "placed into a 500-ml glass beaker,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0017596:Glass [Manufactured Object]
   748   C0439526:/mL [Quantitative Concept]
   748   C1947936:Glass [Medical Device]
   714   C0442504:Place [Spatial Concept]
   714   C1704765:Place [Functional Concept]
   714   C1882509:Place [Activity]
   714   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "the solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "used for distension"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0012359:Distension [Pathologic Function]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "added into the beaker."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.85: This was loaded into a shaking water bath at 37C, activated at 120 rpm. 

Phrase: "This"

Phrase: "was"

Phrase: "loaded into a shaking water bath"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   783   C0179245:bath water [Medical Device]
   753   C0040822:Shaking [Sign or Symptom]
   753   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   753   C0150141:Bath [Therapeutic or Preventive Procedure]
   753   C0599638:WATER [Substance]
   753   C1550678:Water [Inorganic Chemical]
   753   C1708715:Loaded [Activity]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]
   719 E C1883023:Shake [Activity]

Phrase: "at 37C,"

Phrase: "activated at 120 rpm."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0582523:rpm [Quantitative Concept]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.86: After 10 min, the pancreas was shaken with forceps for 60 s; 

Phrase: "After 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "the pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "shaken with forceps"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0016533:Forceps [Medical Device]
   756   C0040822:shake [Sign or Symptom]
   756   C1883023:Shake [Activity]

Phrase: "for 60 s"

Phrase: ";"
Processing 00000000.tx.87: then the digestate was filtered through 300- and 90-m mesh stainless steel filters, in sequence. 

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the digestate"

Phrase: "was"

Phrase: "filtered through 300-"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   756   C0180860:Filter [Manufactured Object]
   756   C0581406:Filter [Medical Device]
   756   C1522664:Filter [Intellectual Product]
   756   C1704449:Filter [Conceptual Entity]
   756   C1704684:Filter [Medical Device]
   756   C1875155:FILTER [Medical Device]
   718 E C0080194:Strain [Injury or Poisoning]
   718 E C0442694:Straining [Physiologic Function]
   718 E C0456178:strain [Intellectual Product]
   718 E C1518614:Strain [Organism]
   718 E C2987481:Strain [Mental Process]

Phrase: "and"

Phrase: "90-m mesh stainless steel filters,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   799   C0180860:Filters [Manufactured Object]
   766 E C0581406:Filter [Medical Device]
   766 E C1522664:Filter [Intellectual Product]
   766 E C1704449:Filter [Conceptual Entity]
   766 E C1704684:Filter [Medical Device]
   766 E C1875155:FILTER [Medical Device]

Phrase: "in sequence."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.88: The solution passed through the filter, and the tissue entrapped on the 300-m mesh filter was placed back into the water bath for further digestion. 

Phrase: "The solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "passed through the filter,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0180860:Filter [Manufactured Object]
   770   C0581406:Filter [Medical Device]
   770   C1522664:Filter [Intellectual Product]
   770   C1704449:Filter [Conceptual Entity]
   770   C1704684:Filter [Medical Device]
   770   C1875155:FILTER [Medical Device]
   770   C2828386:Passed [Finding]

Phrase: "and"

Phrase: "the tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "entrapped on the 300-m mesh filter"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0180860:Filter [Manufactured Object]
   748   C0181805:Mesh [Medical Device]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C0581406:Filter [Medical Device]
   748   C1135584:MeSH [Intellectual Product]
   748   C1522664:Filter [Intellectual Product]
   748   C1552983:Mesh [Quantitative Concept]
   748   C1704449:Filter [Conceptual Entity]
   748   C1704684:Filter [Medical Device]
   748   C1875155:FILTER [Medical Device]

Phrase: "was"

Phrase: "placed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0442504:Place [Spatial Concept]
   966   C1704765:Place [Functional Concept]
   966   C1882509:Place [Activity]
   966   C3496241:place [Disease or Syndrome]

Phrase: "back into the water bath"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004600:Back [Body Location or Region]
   760   C0205095:Back [Spatial Concept]
   760   C0460009:Back [Body Location or Region]
   760   C1995000:Back [Body Location or Region]

Phrase: "for further digestion."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0012238:Digestion [Organism Function]
   861   C2349986:Digestion [Research Activity]
   805 E C0443277:Peptic [Functional Concept]
Processing 00000000.tx.89: The tissue remaining in the 90-m filter was washed with HBSS and 2% human albumin. 

Phrase: "The tissue remaining in the 90-m filter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1527428:Remaining [Qualitative Concept]

Phrase: "was"

Phrase: "washed with HBSS"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   882   C0120742:Hanks Balanced Salt Solution [Pharmacologic Substance]
   833   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]
   773   C0598357:balance salt [Organism Function]
   753   C0036140:Salt [Chemical Viewed Structurally]
   753   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0037633:Solution [Substance]
   753   C0205415:Balanced [Functional Concept]
   753   C0206136:Salt [Food,Inorganic Chemical]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C1548982:Washed [Idea or Concept]
   719 E C0014653:Balance [Organism Function]
   719 E C0441648:Wash [Activity]
   719 E C0560184:Balance [Finding]
   719   C1423529:HANK [Gene or Genome]

Phrase: "and"

Phrase: "2% human albumin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0304925:human albumin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0086418:Human [Human]
Processing 00000000.tx.90: The same procedure of filtration, washing, and settling in HBSS solution was repeated at 810 intervals for up to 4050 min. 

Phrase: "The same procedure of filtration,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   760   C1948041:Procedure [Therapeutic or Preventive Procedure]
   760   C2700391:Procedure [Activity]
   760   C3274430:PROCEDURE [Health Care Activity]
   760   C3538935:Procedure [Idea or Concept]
   760   C3539779:Procedure [Intellectual Product]

Phrase: "washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: ","

Phrase: "and"

Phrase: "settling in HBSS solution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1266099:SETTLE [Neoplastic Process]

Phrase: "was"

Phrase: "repeated at 810 intervals"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   786   C1547391:Repeat interval [Idea or Concept]
   770   C0205341:Repeated [Functional Concept]
   770   C1272706:intervals [Temporal Concept]
   737 E C1547730:Repeat [Temporal Concept]
   737 E C1552654:Interval [Idea or Concept]
   737 E C1552713:Interval [Intellectual Product]
   737 E C1705914:Repeat [Conceptual Entity]

Phrase: "for"

Phrase: "up to 4050 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.91: For purification, 3 ml of tissue was loaded into 220-ml plastic conicals and resuspended in 60 ml of 80% histopaque 1.077 (Sigma) in HBSS, topped with 40 ml of HBSS. 

Phrase: "For purification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "3 ml of tissue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "loaded into 220-ml plastic conicals"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0032167:Plastic [Substance]
   753   C0439526:/mL [Quantitative Concept]
   753   C1708715:Loaded [Activity]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]

Phrase: "and"

Phrase: "resuspended in 60 ml of 80% histopaque 1.077"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0164836:histopaque [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0439526:/mL [Quantitative Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "in HBSS,"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   937   C0120742:Hanks Balanced Salt Solution [Pharmacologic Substance]
   884   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]
   823   C0598357:balance salt [Organism Function]
   804   C0036140:Salt [Chemical Viewed Structurally]
   804   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   804   C0037633:Solution [Substance]
   804   C0150312:In [Quantitative Concept]
   804   C0205415:Balanced [Functional Concept]
   804   C0206136:Salt [Food,Inorganic Chemical]
   804   C0332285:In [Spatial Concept]
   804   C0525069:Solution [Biomedical or Dental Material]
   771 E C0014653:Balance [Organism Function]
   771 E C0560184:Balance [Finding]
   771   C1423529:HANK [Gene or Genome]
   733 E C1537053:salty [Qualitative Concept]
   704 E C0678584:saltiness [Qualitative Concept]

Phrase: "topped with 40 ml of HBSS."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   818   C0120742:Hanks Balanced Salt Solution [Pharmacologic Substance]
   790   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]
   748   C0598357:balance salt [Organism Function]
   742   C0036140:Salt [Chemical Viewed Structurally]
   742   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   742   C0037633:Solution [Substance]
   742   C0205415:Balanced [Functional Concept]
   742   C0206136:Salt [Food,Inorganic Chemical]
   742   C0439509:/40 [Temporal Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C0525069:Solution [Biomedical or Dental Material]
   708 E C0014653:Balance [Organism Function]
   708 E C0560184:Balance [Finding]
   708   C1423529:HANK [Gene or Genome]
   708   C1704458:Top [Spatial Concept]
Processing 00000000.tx.92: After centrifugation at 800g for 5 min at 4C, the islets were recovered at the interface between the two layers. 

Phrase: "After centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "at 800g"

Phrase: "for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "the islets"

Phrase: "were"

Phrase: "recovered at the interface"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0521108:recovered [Qualitative Concept]
   770   C1708533:Interface [Manufactured Object]
   770   C2698172:Interface [Intellectual Product]
   737 E C2004454:recover [Organism Function]

Phrase: "between the two layers."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0934502:layers [Body Part, Organ, or Organ Component]
   827 E C1522408:Layer [Qualitative Concept]
   827 E C1561599:Layer [Intellectual Product]
Processing 00000000.tx.93: The islets were then washed with HBSS and 2% human albumin, centrifuged at 800g for 2 min at 4C, resuspended in M199 culture medium, and cultured at 37C in a CO2 incubator for 56 days to perform the experiments described below. 

Phrase: "The islets"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed with HBSS"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   882   C0120742:Hanks Balanced Salt Solution [Pharmacologic Substance]
   833   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]
   773   C0598357:balance salt [Organism Function]
   753   C0036140:Salt [Chemical Viewed Structurally]
   753   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0037633:Solution [Substance]
   753   C0205415:Balanced [Functional Concept]
   753   C0206136:Salt [Food,Inorganic Chemical]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C1548982:Washed [Idea or Concept]
   719 E C0014653:Balance [Organism Function]
   719 E C0441648:Wash [Activity]
   719 E C0560184:Balance [Finding]
   719   C1423529:HANK [Gene or Genome]

Phrase: "and"

Phrase: "2% human albumin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0304925:human albumin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0086418:Human [Human]

Phrase: "centrifuged at 800g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "for 2 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "resuspended in M199 culture medium,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0439536:Medium [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C2242979:Culture [Laboratory Procedure]
   760   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "cultured at 37C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "in a CO2 incubator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021178:Incubator [Manufactured Object]

Phrase: "for 56 days to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "the experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "described below."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]
Processing 00000000.tx.94: Islet secretory function was evaluated as previously described (2427). 

Phrase: "Islet secretory function"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0544458:Secretory function [Functional Concept]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "was"

Phrase: "evaluated as previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0220825:Evaluated [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(2427"

Phrase: ")."
Processing 00000000.tx.95: After a 30-min preincubation period at 37C in Krebs-Ringer bicarbonate solution with 0.5% albumin (pH 7.4) containing 3.3 mmol/l glucose, the islets were incubated for 45 min in the Krebs-Ringer solution with 1.8, 5.5, or 16.7 mmol/l glucose or 3.3 mmol/l glucose plus 20 mmol/l arginine or 100 mol/l glibenclamide. 

Phrase: "After a 30-min preincubation period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0439531:/period [Temporal Concept]
   812   C1948053:Period [Temporal Concept]
   741 E C0332182:Periodic [Temporal Concept]
   741 E C1706381:PERIODIC [Intellectual Product]
   712 E C0031084:Periodicities [Temporal Concept]

Phrase: "at 37C"

Phrase: "in Krebs-Ringer bicarbonate solution"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0064411:Krebs-Ringer solution [Organic Chemical,Pharmacologic Substance]
           Krebs solution
   875   C0073386:Ringer's solution [Inorganic Chemical,Pharmacologic Substance]
   812   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   812   C0037633:Solution [Substance]
   812   C0525069:Solution [Biomedical or Dental Material]
   812   C0973231:Bicarbonate [Inorganic Chemical]
   812   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   812   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "with 0.5% albumin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "3.3 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "the islets"

Phrase: "were"

Phrase: "incubated for 45 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in the Krebs-Ringer solution"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0064411:Krebs-Ringer solution [Organic Chemical,Pharmacologic Substance]
           Krebs solution
   901   C0073386:Ringer's solution [Inorganic Chemical,Pharmacologic Substance]
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]
   827   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]

Phrase: "with 1.8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "5.5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450380:5/5 [Quantitative Concept]
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "or"

Phrase: "16.7 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "or"

Phrase: "3.3 mmol/l glucose plus 20 mmol/l arginine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "or"

Phrase: "100 mol/l glibenclamide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.96: At the end of the incubation time, aliquots of the incubation medium were taken for insulin (Medgenix Diagnostics, Fleurs, Belgium; no cross-reactivity with human proinsulin) and proinsulin (Tecnogenetics, Turin, Italy; cross-reactivity with human insulin of <0.1%) immunoassay measurement. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the incubation time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "aliquots of the incubation medium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "taken for insulin"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Medgenix Diagnostics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011900:Diagnostic [Finding]
   827   C0348026:Diagnostic [Functional Concept]

Phrase: "Fleurs,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: ";"

Phrase: "no cross-reactivity with human proinsulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0010357:Cross Reactivity [Molecular Function]
   790   C0872139:cross reactivity [Molecular Function]
   790   C1880190:CROSS REACTIVITY [Event]
   753   C2828360:Cross [Conceptual Entity]

Phrase: ")"

Phrase: "and"

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Tecnogenetics,"

Phrase: "Turin,"

Phrase: "Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: "; cross-reactivity with human insulin of <0.1%"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0010357:Cross Reactivity [Molecular Function]
   770   C0872139:cross reactivity [Molecular Function]
   770   C1880190:CROSS REACTIVITY [Event]
   744   C2828360:Cross [Conceptual Entity]

Phrase: ")"

Phrase: "immunoassay measurement."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.97: Islet insulin extraction was performed at the end of the incubation by overnight acid-alcohol incubation. 

Phrase: "Islet insulin extraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185115:Extraction [Therapeutic or Preventive Procedure]
   827   C0684295:extraction [Laboratory Procedure]

Phrase: "was"

Phrase: "performed at the end of the incubation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0444930:End [Spatial Concept]
   748   C0884358:Performed [Functional Concept]
   748   C2746065:End [Temporal Concept]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "by overnight acid-alcohol incubation."
Processing 00000000.tx.98: Glucose utilization and oxidation were determined at low (3.3 mmol/l) and high (16.7 mmol/l) glucose by measuring the formation of 3H2O from [5-3H]glucose and 14CO2 from [U- 14C]glucose, respectively, according to methods previously reported in detail (35). 

Phrase: "Glucose utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042153:utilization [Functional Concept]

Phrase: "and"

Phrase: "oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "were"

Phrase: "determined at low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205251:low [Qualitative Concept]
   790   C1299352:Low [Qualitative Concept]
   790   C1550472:low [Idea or Concept]

Phrase: "(3.3 mmol/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439190:MMOLE [Quantitative Concept]

Phrase: "l)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "(16.7 mmol/l) glucose by measuring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "the formation of 3H2O"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "from"

Phrase: "[5-3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "]glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "14CO2 from"

Phrase: "[U- 14C"

Phrase: "]glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "respectively,"

Phrase: "according to methods previously"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "reported in detail"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C1522508:Detail [Qualitative Concept]
   790   C1561567:detail [Functional Concept]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.99: Electron microscopy evaluation and quantification of - and -cells, as well as insulin secretory granules, were performed according to standard procedures (36,37). 

Phrase: "Electron microscopy evaluation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0220825:Evaluation [Functional Concept]
   827   C1261322:Evaluation [Health Care Activity]
   734   C0026019:Electron Microscopy [Laboratory Procedure]
   734   C2984656:ELECTRON MICROSCOPY [Functional Concept]

Phrase: "and"

Phrase: "quantification of -"

Phrase: "and -"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "as well as"

Phrase: "insulin secretory granules,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0886515:Secretory Granules [Cell Component]
   867 E C3271154:Secretory Granule [Cell Component]
   827   C0010837:Granules [Cell Component]
   827   C0993609:Granules [Biomedical or Dental Material]
   827   C1327616:Secretory [Cell Function]
   743 E C0205248:Granular [Qualitative Concept]

Phrase: "were"

Phrase: "performed according to standard procedures"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   781   C2985643:Performed Procedure [Research Activity]
   760   C0025664:procedures [Intellectual Product]
   760   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   760   C0680240:according [Social Behavior]
   760   C0884358:Performed [Functional Concept]
   760   C1442989:Standard [Qualitative Concept]
   760   C2700391:procedures [Activity]
   760   C2828392:Standard [Intellectual Product]
   726 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   726 E C2947996:Perform [Pharmacologic Substance]
   726 E C3274430:PROCEDURE [Health Care Activity]
   726 E C3538935:Procedure [Idea or Concept]
   726 E C3539779:Procedure [Intellectual Product]

Phrase: "(36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.100: RNA extraction from human islets and semiquantitative RT-PCR analysis of insulin and insulin housekeeping control genes was performed as previously described (38). 

Phrase: "RNA extraction from human islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0185115:Extraction [Therapeutic or Preventive Procedure]
   760   C0684295:extraction [Laboratory Procedure]

Phrase: "and"

Phrase: "semiquantitative RT-PCR analysis of insulin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0200931:PCR analysis [Laboratory Procedure]
   790   C0599161:RT-PCR [Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0677874:pCR [Finding]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "insulin housekeeping control genes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   886   C1337112:Insulin Gene [Gene or Genome]
   875   C1334046:Genes, House-keeping [Gene or Genome]
   812   C0017337:Genes [Gene or Genome]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.101: Results are given as means  SD. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "given as means  SD."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C1442162:GIVEN [Conceptual Entity]
   770   C1550718:given [Idea or Concept]
   770   C1704970:Means [Conceptual Entity]
   770   C3244317:given [Intellectual Product]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C1947971:Give [Functional Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.102: Comparison of data were performed by ANOVA or the two-tailed Students t test.  

Phrase: "Comparison of data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "were"

Phrase: "performed by ANOVA"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "or"

Phrase: "the two-tailed Students t test."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   804   C0022885:Test [Laboratory Procedure]
   804   C0038492:Students [Professional or Occupational Group]
   804   C0039593:Test [Functional Concept]
   804   C0392366:test [Intellectual Product]
   771 E C1551041:student [Idea or Concept]
   771 E C1552573:student [Intellectual Product]
Processing 00000000.tx.103: ACKNOWLEDGMENTS  This work was supported in part by European Community Grant QLG1-CT-1999-00674 (G.S.) and COFIN 1999 and 2000 from the Italian Ministero dellUniversit e Ricerca Scientifica e Tecnologica.  

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by European Community Grant QLG1-CT-1999-00674"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   818   C0015179:European Community [Organization]
   795   C0009462:Community [Geographic Area]
   795   C0018173:Grant [Quantitative Concept]
   795   C0239307:European [Population Group]
   795   C1535514:European [Population Group]
   795   C1548284:Grant [Idea or Concept]
   795   C3540513:CT [Gene or Genome]

Phrase: "(G.S.)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086903:G S [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827790:g/s [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "COFIN 1999"

Phrase: "and"

Phrase: "2000 from the Italian Ministero dellUniversit e Ricerca Scientifica e Tecnologica."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0022275:ITALIAN [Language]
   738   C0337810:Italian [Population Group]
Processing 00000000.tx.104: FOOTNOTES  Address correspondence and reprint requests to Piero Marchetti, MD, Department of Endocrinology and Metabolism, Metabolic Unit, Ospedale Cisanello, via Paradisa 2, 56100 - Pisa, Italy. 

Phrase: "FOOTNOTES  Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Piero Marchetti,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0686900:request [Functional Concept]
   770   C1272683:Request [Functional Concept]
   770   C1522634:Request [Intellectual Product]

Phrase: "MD,"

Phrase: "Department of Endocrinology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587463:Endocrinology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "Metabolic Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439148:Unit [Quantitative Concept]
   861   C1519795:Unit [Quantitative Concept]
   861   C1704753:Unit [Manufactured Object]
   861   C1880519:Unit [Quantitative Concept]

Phrase: "Ospedale Cisanello,"

Phrase: "via Paradisa 2,"

Phrase: "56100 - Pisa,"

Phrase: "Italy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]
Processing 00000000.tx.105: E-mail: marchant{at}immr.med.unipi.it . Received for publication 26 June 2001 and accepted in revised form 14 January 2002. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "marchant{at}immr.med.unipi."

Phrase: "it ."

Phrase: "Received for publication 26 June 2001"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0034036:Publication [Intellectual Product,Manufactured Object]
   753   C0034037:Publication [Occupational Activity]
   753   C1514756:Received [Qualitative Concept]
   753   C1704324:Publication [Intellectual Product]

Phrase: "and"

Phrase: "accepted in revised form 14 January 2002."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   748   C1527075:Revised [Therapeutic or Preventive Procedure]
   748   C1548435:Accepted [Idea or Concept]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.106: HBSS, Hanks balanced salt solution; 

Phrase: "HBSS,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0120742:Hanks Balanced Salt Solution [Pharmacologic Substance]
   923   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]
   812   C0036140:Salt [Chemical Viewed Structurally]
   812   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0037633:Solution [Substance]
   812   C0206136:Salt [Food,Inorganic Chemical]
   812   C0525069:Solution [Biomedical or Dental Material]
   741 E C1537053:salty [Qualitative Concept]
   712 E C0678584:saltiness [Qualitative Concept]

Phrase: "Hanks balanced salt solution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0120742:Hanks Balanced Salt Solution [Pharmacologic Substance]
   779   C1423529:HANK [Gene or Genome]
   756   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.107: IRS-1, insulin receptor substrate 1; 

Phrase: "IRS-1,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin receptor substrate 1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.108: PC 1/3, prohormone convertase 1/3; 

Phrase: "PC 1/3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0135615:Prohormone Convertase 1 [Amino Acid, Peptide, or Protein,Enzyme]
           Prohormone Convertase 3
   923   C1418388:PROHORMONE CONVERTASE 1 [Gene or Genome]
           PROHORMONE CONVERTASE 3
   861   C1258132:Prohormone Convertase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0301817:Prohormone [Hormone]

Phrase: "prohormone convertase 1/3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0135615:Prohormone Convertase 1 [Amino Acid, Peptide, or Protein,Enzyme]
           Prohormone Convertase 3
   923   C1418388:PROHORMONE CONVERTASE 1 [Gene or Genome]
           PROHORMONE CONVERTASE 3
   861   C1258132:Prohormone Convertase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0301817:Prohormone [Hormone]

Phrase: ";"
Processing 00000000.tx.109: PDX-1, pancreatic duodenal homeobox 1; 

Phrase: "PDX-1,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0013303:Duodenal [Body Part, Organ, or Organ Component]
   812   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   812   C0242303:Homeo Box [Gene or Genome]
   812   C0598306:Homeo Box [Spatial Concept]
   741 E C1278921:Duodenum [Body Part, Organ, or Organ Component]

Phrase: "pancreatic duodenal homeobox 1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0013303:Duodenal [Body Part, Organ, or Organ Component]
   812   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   812   C0242303:Homeo Box [Gene or Genome]
   812   C0598306:Homeo Box [Spatial Concept]
   741 E C1278921:Duodenum [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.110: PI, phosphatidylinositol.  

Phrase: "PI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
  1000   C2348046:Phosphatidylinositol [Lipid]

Phrase: "phosphatidylinositol."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
  1000   C2348046:Phosphatidylinositol [Lipid]
Processing 00000000.tx.111: REFERENCES TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS REFERENCES  Mandroup-Poulsen T. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mandroup-Poulsen T."
Processing 00000000.tx.112: Diabetes. 

Phrase: "Diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.113: BMJ316 :1221 1225,1998[Free FullText] Cavaghan MK, Ehrmann DA, Polonski KS: Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. 

Phrase: "BMJ316"

Phrase: ":"

Phrase: "1221 1225,"

Phrase: "1998"

Phrase: "[Free FullText"

Phrase: "] Cavaghan MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Ehrmann DA,"

Phrase: "Polonski KS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: ":"

Phrase: "Interactions between insulin resistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "insulin secretion in the development of glucose intolerance."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1256369:insulin secretion [Cell Function]
   767   C1719133:Glucose/Insulin [Quantitative Concept]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.114: J Clin Invest106 :329 333,2000[Free FullText] Ferrannini E: Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. 

Phrase: "J Clin Invest106"

Phrase: ":"

Phrase: "329 333,"

Phrase: "2000"

Phrase: "[Free FullText"

Phrase: "] Ferrannini E"

Phrase: ":"

Phrase: "Insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "versus"

Phrase: "insulin deficiency in non-insulin-dependent diabetes mellitus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0011155:Deficiency [Functional Concept]
   744   C0162429:Deficiency [Disease or Syndrome]
   744   C1623416:deficiency [Qualitative Concept]
   703   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
   703   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]

Phrase: ":"

Phrase: "problems"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1546466:Problems [Idea or Concept]
   966 E C0033213:Problem [Finding]

Phrase: "and"

Phrase: "prospects."
Processing 00000000.tx.115: Endocr Rev19 :477 490,1998[Abstract/Free FullText] Ghosh S, Schork NJ: Genetic analysis of NIDDM. 

Phrase: "Endocr Rev19"

Phrase: ":"

Phrase: "477 490,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ghosh S,"

Phrase: "Schork NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: ":"

Phrase: "Genetic analysis of NIDDM."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0679560:genetic analysis [Laboratory Procedure]
   833   C0796344:Genetic Analysis [Laboratory Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.116: Diabetes45 :544 551,1996[Abstract] Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O: Amino acid polymorphism of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. 

Phrase: "Diabetes45"

Phrase: ":"

Phrase: "544 551,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Almind K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Bjorbaek C,"

Phrase: "Vestergaard H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hansen T,"

Phrase: "Echwald S,"

Phrase: "Pedersen O"

Phrase: ":"

Phrase: "Amino acid polymorphism of insulin receptor substrate-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0032529:Polymorphism [Genetic Function]
   744   C1882417:Polymorphism [Qualitative Concept]

Phrase: "in non-insulin-dependent diabetes mellitus."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.117: Lancet342 :828 832,1993[Medline] Giovannone B, Scaldaferri ML, Federici M, Porzio O, Lauro D, Fusco A, Sbraccia P, Borboni P, Lauro R, Sesti G: Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling potential. 

Phrase: "Lancet342"

Phrase: ":"

Phrase: "828 832,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Giovannone B,"

Phrase: "Scaldaferri ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Federici M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Porzio O,"

Phrase: "Lauro D,"

Phrase: "Fusco A,"

Phrase: "Sbraccia P,"

Phrase: "Borboni P,"

Phrase: "Lauro R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Sesti G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Insulin receptor substrate (IRS) transduction system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: ":"

Phrase: "distinct"

Phrase: "and"

Phrase: "overlapping signaling potential."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.118: Diabetes Metab Res Rev16 :434 441,2000[Medline] Hirayama I, Tamemoto H, Yokota H, Kubo SK, Wang J, Kuwano H, Nagamachi Y, Takeuchi T, Izumi T: Insulin receptor-related receptor is expressed in pancreatic beta cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2. 

Phrase: "Diabetes Metab Res Rev16"

Phrase: ":"

Phrase: "434 441,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hirayama I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Tamemoto H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Yokota H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kubo SK,"

Phrase: "Wang J,"

Phrase: "Kuwano H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Nagamachi Y,"

Phrase: "Takeuchi T,"

Phrase: "Izumi T"

Phrase: ":"

Phrase: "Insulin receptor-related receptor"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
  1000   C0083017:insulin receptor-related receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1416459:INSULIN RECEPTOR-RELATED RECEPTOR [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   779 E C0163712:Relate [Organic Chemical]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "expressed in pancreatic beta cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   862   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   760   C0007634:Cells [Cell]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0330390:Beta [Plant]
   760   C0439096:Beta [Intellectual Product]
   760   C2004068:Beta [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "stimulates"

Phrase: "tyrosine phosphorylation of insulin receptor substrate-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1519726:Tyrosine Phosphorylation [Molecular Function]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "and -"

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.119: Diabetes48 :1237 1244,1999[Abstract] Sigal RJ, Doria A, Warram JH, Krolewski AS: Codon 972 polymorphism in the insulin receptor substrate-1 gene, obesity and risk of non-insulin-dependent diabetes mellitus. 

Phrase: "Diabetes48"

Phrase: ":"

Phrase: "1237 1244,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sigal RJ,"

Phrase: "Doria A,"

Phrase: "Warram JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Krolewski"

Phrase: "AS"

Phrase: ":"

Phrase: "Codon 972 polymorphism in the insulin receptor substrate-1 gene,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0678951:gene polymorphism [Genetic Function]
   739   C0032529:Polymorphism [Genetic Function]
   739   C1882417:Polymorphism [Qualitative Concept]

Phrase: "obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "and"

Phrase: "risk of non-insulin-dependent diabetes mellitus."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0743140:diabetes mellitus risk [Disease or Syndrome]
   774   C1171304:diabetes risk [Quantitative Concept]
   748   C0035647:Risk [Qualitative Concept]
   731   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
   731   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
Processing 00000000.tx.120: J Clin Endocrinol Metab81 :1657 1659,1996[Abstract] Imai Y, Fusco A, Suzuki Y, Lesniak MA, DAlfonso R, Sesti G, Bertoli A, Lauro R, Accili D, Taylor SI: Variant sequences of insulin receptor substrate-1 in patients with non insulin dependent diabetes mellitus. 

Phrase: "J Clin Endocrinol Metab81"

Phrase: ":"

Phrase: "1657 1659,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Imai Y,"

Phrase: "Fusco A,"

Phrase: "Suzuki Y,"

Phrase: "Lesniak MA,"

Phrase: "DAlfonso R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Sesti G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Bertoli A,"

Phrase: "Lauro R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Accili D,"

Phrase: "Taylor SI"

Phrase: ":"

Phrase: "Variant sequences of insulin receptor substrate-1"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0162326:Sequences [Nucleotide Sequence]
   714 E C0004793:Sequence [Nucleotide Sequence]
   714 E C0162327:Sequence [Nucleotide Sequence]
   714 E C1519249:Sequence [Functional Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with non insulin dependent diabetes mellitus."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.121: J Clin Endocrinol Metab79 :1655 1658,1994[Abstract] Laakso M, Malkki M, Kekalainen P, Kuusisto J, Deeb S: Insulin receptor substrate-1 variants in non-insulin-dependent diabetes. 

Phrase: "J Clin Endocrinol Metab79"

Phrase: ":"

Phrase: "1655 1658,"

Phrase: "1994"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Laakso M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Malkki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kekalainen P,"

Phrase: "Kuusisto J,"

Phrase: "Deeb S"

Phrase: ":"

Phrase: "Insulin receptor substrate-1 variants in non-insulin-dependent diabetes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205419:variants [Qualitative Concept]
Processing 00000000.tx.122: J Clin Invest94 :1141 1146,1994[Medline] Zhang Y, Wat N, Stratton IM, Warren-Perry MG, Orho M, Groop L, Turner RC, UKPDS 19: Heterogeneity in NIDDM: separate contributions of IRS-1 and beta3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. 

Phrase: "J Clin Invest94"

Phrase: ":"

Phrase: "1141 1146,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zhang Y,"

Phrase: "Wat N,"

Phrase: "Stratton IM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539078:IM [Idea or Concept]

Phrase: "Warren-Perry MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Orho M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Groop L,"

Phrase: "Turner RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "UKPDS 19"

Phrase: ":"

Phrase: "Heterogeneity in NIDDM"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0019409:Heterogeneity [Qualitative Concept]
   706 E C1512426:Heterogenous [Idea or Concept]

Phrase: ":"

Phrase: "separate contributions of IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "beta3-adrenergic-receptor mutations to insulin resistance"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "obesity respectively with no evidence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0028754:Obesity [Disease or Syndrome]
   760   C1963185:Obesity [Finding]

Phrase: "for glycogen synthase gene mutations."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0596611:gene mutations [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.123: Diabetologia39 :1505 1511,1996[Medline] Mori H, Hashiramoto M, Kishimoto M, Kasuga M: Aminoacid polymorphism of the insulin receptor substrate-1 in Japanese non-insulin-dependent diabetes mellitus. 

Phrase: "Diabetologia39"

Phrase: ":"

Phrase: "1505 1511,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mori H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hashiramoto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kishimoto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kasuga M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Aminoacid polymorphism of the insulin receptor substrate-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0032529:Polymorphism [Genetic Function]
   744   C1882417:Polymorphism [Qualitative Concept]

Phrase: "in Japanese non-insulin-dependent diabetes mellitus."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   947   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
   947   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   901   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   827   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   799   C0011847:Diabetes [Disease or Syndrome]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0851827:Dependent [Qualitative Concept]
   799   C1518422:Non [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1701901:Dependent [Qualitative Concept]
   799   C3244310:dependent [Functional Concept]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.124: J Clin Endocrinol Metab80 :2822 2826,1995[Abstract] Ura S, Araki E, Kishikawa H, Shirotani T, Todaka M, Isami S, Shimoda S, Yoshimura R, Matsuda K, Motoyoshi S, Miyamura N, Kahn CR, Shichiri M: Molecular scanning of the IRS-1 gene in Japanese patients with non-insulin-dependent diabetes mellitus: identification of five novel mutations in IRS-1 gene. 

Phrase: "J Clin Endocrinol Metab80"

Phrase: ":"

Phrase: "2822 2826,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ura S,"

Phrase: "Araki E,"

Phrase: "Kishikawa H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Shirotani T,"

Phrase: "Todaka M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Isami S,"

Phrase: "Shimoda S,"

Phrase: "Yoshimura R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Matsuda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Motoyoshi S,"

Phrase: "Miyamura N,"

Phrase: "Kahn CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "Shichiri M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Molecular scanning of the IRS-1 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0034606:Scanning [Diagnostic Procedure]
   742   C0441633:Scanning [Diagnostic Procedure]

Phrase: "in Japanese patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with non-insulin-dependent diabetes mellitus"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "identification of five novel mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "in IRS-1 gene."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1334140:Insulin Receptor Substrate 1 Gene [Gene or Genome]
           INSULIN RECEPTOR SUBSTRATE 1
   911   C1334133:Insulin Receptor Gene [Gene or Genome]
   897   C1337112:Insulin Gene [Gene or Genome]
   875   C1335671:Receptor Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   771   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.125: Diabetologia39 :600 608,1996[Medline] Clausen JO, Hansen T, Bjorbaek C, Echwald SM, Urhammer SA, Rasmussen S, Andersen CB, Hansen L, Almind K, Winther K, et al.: 

Phrase: "Diabetologia39"

Phrase: ":"

Phrase: "600 608,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Clausen JO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022418:JO [Geographic Area]

Phrase: "Hansen T,"

Phrase: "Bjorbaek C,"

Phrase: "Echwald SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Urhammer SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Rasmussen S,"

Phrase: "Andersen CB,"

Phrase: "Hansen L,"

Phrase: "Almind K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Winther K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "et al."

Phrase: ":"
Processing 00000000.tx.126: Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. 

Phrase: "Insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "interactions between obesity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "a common variant of insulin receptor substrate-1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205419:Variant [Qualitative Concept]
Processing 00000000.tx.127: Lancet346 :397 402,1995[Medline] Hribal ML, Federici M, Porzio O, Lauro D, Borboni P, Accili D, Lauro R, Sesti G: The Gly->Arg72amino: acid polymorphism in IRS-1 affects glucose metabolism in skeletal muscle cells. 

Phrase: "Lancet346"

Phrase: ":"

Phrase: "397 402,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hribal ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Federici M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Porzio O,"

Phrase: "Lauro D,"

Phrase: "Borboni P,"

Phrase: "Accili D,"

Phrase: "Lauro R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Sesti G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "The Gly-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017890:Gly [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ">Arg72amino"

Phrase: ":"

Phrase: "acid polymorphism in IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0032529:Polymorphism [Genetic Function]
   748   C1882417:Polymorphism [Qualitative Concept]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "glucose metabolism in skeletal muscle cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0596620:glucose metabolism [Molecular Function]
   783   C0596984:metabolism muscle [Organ or Tissue Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.128: J Clin Endocrinol Metab85 :2004 2013,2000[Abstract/Free FullText] Koch M, Rett K, Volk A, Maerker E, Haist K, Deninger M, Renn W, Haring HU: Amino acid polymorphism Gly972 Arg in IRS-1 is not associated to lower clamp-derived insulin sensitivity in young healthy first degree relatives of patients with type 2 diabetes. 

Phrase: "J Clin Endocrinol Metab85"

Phrase: ":"

Phrase: "2004 2013,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Koch M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Rett K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Volk A,"

Phrase: "Maerker E,"

Phrase: "Haist K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Deninger M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Renn W,"

Phrase: "Haring"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0242372:haring [Mammal]
   966 E C1425660:HARE [Gene or Genome]

Phrase: "HU"

Phrase: ":"

Phrase: "Amino acid polymorphism Gly972 Arg in IRS-1"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "clamp-derived insulin sensitivity in young healthy first degree relatives of patients"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0920563:Insulin Sensitivity [Pathologic Function]
   736   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   736   C0036667:Sensitivity [Quantitative Concept]
   736   C0312418:Sensitivity [Mental Process]
   736   C0427965:Sensitivity [Finding]
   736   C1511883:Sensitivity [Quantitative Concept]
   736   C1522640:Sensitivity [Qualitative Concept]
   736   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   736   C1579433:Insulin [Pharmacologic Substance]
   736   C2346484:SENSITIVITY [Phenomenon or Process]
   736   C2349185:Sensitivity [Qualitative Concept]

Phrase: "with type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.129: Exp Clin Endocrinol Diabetes107 :318 322,1999[Medline] Armstrong M, Haldane F, Avery PJ, Mitcheson J, Stewart MW, Turnbull DM, Walker M: Relationship between insulin sensitivity and insulin receptor substrate-1 mutations in non-diabetic relatives of NIDDM families. 

Phrase: "Exp Clin Endocrinol Diabetes107"

Phrase: ":"

Phrase: "318 322,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Armstrong M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Haldane F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Avery PJ,"

Phrase: "Mitcheson J,"

Phrase: "Stewart MW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: "Turnbull DM,"

Phrase: "Walker M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Relationship between insulin sensitivity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "insulin receptor substrate-1 mutations in non-diabetic relatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0026882:Mutations [Genetic Function]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "of NIDDM families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.130: Diabet Med13 :341 345,1996[Medline] Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF: Disruption of IRS-2 causes type 2 diabetes in mice. 

Phrase: "Diabet Med13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1427770:MED13 [Gene or Genome]

Phrase: ":"

Phrase: "341 345,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "Withers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230107:Withers [Body Part, Organ, or Organ Component]

Phrase: "DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012836:DJ [Geographic Area]

Phrase: "Gutierrez JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Towery H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Burks DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Ren JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Previs S,"

Phrase: "Zhang Y,"

Phrase: "Bernal D,"

Phrase: "Pons S,"

Phrase: "Shulman GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "Bonner-Weir S,"

Phrase: "White MF"

Phrase: ":"

Phrase: "Disruption of IRS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0332453:Disruption [Functional Concept]
   716   C0381451:Insulin Receptor Substrate-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   716   C1334141:INSULIN RECEPTOR SUBSTRATE 2 [Gene or Genome]
   716   C1334191:Insulin Receptor Substrate 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "type 2 diabetes in mice."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.131: Nature391 :900 903,1998[Medline] Stumvoll M, Fritsche A, Volke A, Stefan N, Madaus A, Maerker E, Teigeler A, Koch M, Machicao F, Haring H: The Gly972Arg polymorphism in the insulin receptor substrate-1 gene contributes to the variation in insulin secretion in normal glucose-tolerant humans. 

Phrase: "Nature391"

Phrase: ":"

Phrase: "900 903,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stumvoll M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Fritsche A,"

Phrase: "Volke A,"

Phrase: "Stefan N,"

Phrase: "Madaus"

Phrase: "A,"

Phrase: "Maerker E,"

Phrase: "Teigeler A,"

Phrase: "Koch M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Machicao F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Haring"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0242372:haring [Mammal]
   966 E C1425660:HARE [Gene or Genome]

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "The Gly972Arg polymorphism in the insulin receptor substrate-1 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0678951:gene polymorphism [Genetic Function]
   739   C0032529:Polymorphism [Genetic Function]
   739   C1882417:Polymorphism [Qualitative Concept]

Phrase: "contributes to the variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205419:Variation [Qualitative Concept]
   770   C1880177:Contribute [Activity]

Phrase: "in insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in normal glucose-tolerant humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086418:Humans [Human]
Processing 00000000.tx.132: Diabetes50 :882 885,2001[Abstract/Free FullText] Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR: Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. 

Phrase: "Diabetes50"

Phrase: ":"

Phrase: "882 885,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kulkarni RN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540639:RN [Gene or Genome]

Phrase: "Bruning JC,"

Phrase: "Winnay JN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428813:JN [Gene or Genome]

Phrase: "Postic C,"

Phrase: "Magnuson MA,"

Phrase: "Kahn CR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: ":"

Phrase: "Tissue-specific knockout of the insulin receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0560617:knock out [Injury or Poisoning]
   748   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "in pancreatic beta cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   827   C0007634:Cells [Cell]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "creates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "an insulin secretory defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1457869:Defect [Functional Concept]
   827   C1861101:DEFECT [Disease or Syndrome]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "in type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.133: Cell96 :329 339,1999[Medline] Kulkarni RN, Winnay JN, Daniels M, Bruning JC, Flier SN, Hanahan, D, Kahn CR: Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. 

Phrase: "Cell96"

Phrase: ":"

Phrase: "329 339,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kulkarni RN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540639:RN [Gene or Genome]

Phrase: "Winnay JN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428813:JN [Gene or Genome]

Phrase: "Daniels M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bruning JC,"

Phrase: "Flier SN,"

Phrase: "Hanahan,"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Kahn CR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: ":"

Phrase: "Altered function of insulin receptor substrate-1-deficient mouse islets"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0920644:function receptor [Molecular Function]
   739   C0031843:function [Physiologic Function]
   739   C0542341:Function [Functional Concept]
   739   C0700205:FUNCTION [Classification]
   739   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "cultured beta-cell lines."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   906   C0007600:Cultured Cell Line [Cell]
           Cell lines
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]
   708   C0007635:cultured cell [Cell]
Processing 00000000.tx.134: J Clin Invest104 :R69 R75,1999[Medline] Porzio O, Federici M, Hribal ML, Lauro D, Accili D, Lauro R, Borboni P, Sesti G: The Gly 972 Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells. 

Phrase: "J Clin Invest104"

Phrase: ":"

Phrase: "R69 R75,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Porzio O,"

Phrase: "Federici M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hribal ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Lauro D,"

Phrase: "Accili D,"

Phrase: "Lauro R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Borboni P,"

Phrase: "Sesti G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "The Gly 972 Arg amino acid polymorphism in IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0032529:Polymorphism [Genetic Function]
   736   C1882417:Polymorphism [Qualitative Concept]

Phrase: "impairs"

Phrase: "insulin secretion in pancreatic beta cells."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1256369:insulin secretion [Cell Function]
   783   C0030296:Pancreatic Secretion [Body Substance]
   783   C0232787:Pancreatic secretion [Organ or Tissue Function]
   767   C0030281:Insulin Cell [Cell]
   767   C1327616:Cell secretion [Cell Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.135: J Clin Invest104 :357 364,1999[Abstract/Free FullText] Federici M, Hribal ML, Ranalli M, Marselli L, Porzio O, Lauro D, Borboni P, Lauro R, Marchetti P, Melino G, Sesti G: The common Arg972 polymorphism in insulin receptor substrate-1 causes apoptosis of human pancreatic islets. 

Phrase: "J Clin Invest104"

Phrase: ":"

Phrase: "357 364,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Federici M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hribal ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Ranalli M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Marselli L,"

Phrase: "Porzio O,"

Phrase: "Lauro D,"

Phrase: "Borboni P,"

Phrase: "Lauro R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Marchetti P,"

Phrase: "Melino G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Sesti G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "The common Arg972 polymorphism in insulin receptor substrate-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0032529:Polymorphism [Genetic Function]
   742   C1882417:Polymorphism [Qualitative Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "apoptosis of human pancreatic islets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.136: FASEB J15 :22 24,2001[Abstract/Free FullText] Marchetti P, Dotta F, Ling Z, Lupi R, Del Guerra S, Santangelo C, Realacci M, Marselli L, Di Mario U, Navalesi R: The function of pancreatic islets isolated from type 1 diabetic patient. 

Phrase: "FASEB J15"

Phrase: ":"

Phrase: "22 24,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Marchetti P,"

Phrase: "Dotta F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Ling Z,"

Phrase: "Lupi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Del Guerra S,"

Phrase: "Santangelo C,"

Phrase: "Realacci M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Marselli L,"

Phrase: "Di Mario U,"

Phrase: "Navalesi R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "The function of pancreatic islets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0597166:pancreatic islet function [Organ or Tissue Function]
   797   C0232786:Pancreatic function [Organ or Tissue Function]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "isolated from type 1 diabetic patient."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0441729:Type 1 [Classification]
   783   C1550335:Patient type [Classification]
   753   C0030705:*^patient [Patient or Disabled Group]
   753   C0205409:Isolated [Functional Concept]
   753   C0241863:DIABETIC [Finding]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.137: Diabetes Care23 :701 703,2000[Free FullText] Rosati B, Marchetti P, Crociani O, Lecchi M, Lupi R, Arcangeli A, Olivotto M, Wanke E: Glucose- and arginine-induced insulin secretion by human pancreatic beta-cells: the role of HERG K(+) channels in firing and release. 

Phrase: "Diabetes Care23"

Phrase: ":"

Phrase: "701 703,"

Phrase: "2000"

Phrase: "[Free FullText"

Phrase: "] Rosati B,"

Phrase: "Marchetti P,"

Phrase: "Crociani O,"

Phrase: "Lecchi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lupi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Arcangeli A,"

Phrase: "Olivotto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wanke E"

Phrase: ":"

Phrase: "Glucose-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "arginine-induced insulin secretion by human pancreatic beta-cells"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   773   C1327616:secretion by cell [Cell Function]
           Cell secretion
   764   C1256369:insulin secretion [Cell Function]
   762   C0030296:Pancreatic Secretion [Body Substance]
   762   C0232787:Pancreatic secretion [Organ or Tissue Function]
   762   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   762   C1955116:Arginine+Insulin [Laboratory Procedure]
   745   C0030281:Insulin Cell [Cell]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]

Phrase: ":"

Phrase: "the role of HERG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "K(+)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "channels in firing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439799:Channel [Spatial Concept]
   790   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "release."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.138: FASEB J14 :2601 2610,2000[Abstract/Free FullText] Piro S, Lupi R, Dotta F, Patane G, Rabuazzo MA, Marselli L, Santangelo C, Realacci M, Del Guerra S, Purrello F, Marchetti P: Bovine islets are less susceptible than human islets to damage by human cytokines. 

Phrase: "FASEB J14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442783:J14 [Finding]

Phrase: ":"

Phrase: "2601 2610,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Piro S,"

Phrase: "Lupi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Dotta F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Patane G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Rabuazzo MA,"

Phrase: "Marselli L,"

Phrase: "Santangelo C,"

Phrase: "Realacci M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Del Guerra S,"

Phrase: "Purrello F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Marchetti P"

Phrase: ":"

Phrase: "Bovine islets"

Phrase: "are"

Phrase: "less susceptible than human islets to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0231204:Susceptible [Functional Concept]
   753   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "damage by human cytokines."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0010957:Damage [Injury or Poisoning]
   770   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0086418:Human [Human]
   770   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1883709:Damage [Functional Concept]
Processing 00000000.tx.139: Transplantation71 :21 26,2001[Medline] Lupi R, Del Guerra S, Tellini C, Giannarelli R, Coppelli A, Lorenzetti M, Carmellini M, Mosca F, Navalesi R, Marchetti P: The biguanide compound metformin prevents desensitization of human pancreatic islets induced by high glucose. 

Phrase: "Transplantation71"

Phrase: ":"

Phrase: "21 26,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lupi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Del Guerra S,"

Phrase: "Tellini C,"

Phrase: "Giannarelli R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Coppelli A,"

Phrase: "Lorenzetti M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Carmellini M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Mosca F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Navalesi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Marchetti P"

Phrase: ":"

Phrase: "The biguanide compound metformin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025598:Metformin [Organic Chemical,Pharmacologic Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "desensitization of human pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   760   C1709852:Desensitization [Molecular Function]

Phrase: "induced by high glucose."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0860803:high glucose [Finding]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0205250:High [Qualitative Concept]
   770   C0205263:Induced [Functional Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.140: Eur J Pharmacol364 :205 209,1999[Medline] Aspinwall CA, Lakey JRT, Kennedy RT: Insulin-stimulated insulin secretion in single pancreatic beta cells. 

Phrase: "Eur J Pharmacol364"

Phrase: ":"

Phrase: "205 209,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Aspinwall CA,"

Phrase: "Lakey JRT,"

Phrase: "Kennedy RT"

Phrase: ":"

Phrase: "Insulin-stimulated insulin secretion in single pancreatic beta cells."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0030296:Pancreatic Secretion [Body Substance]
   762   C0232787:Pancreatic secretion [Organ or Tissue Function]
   762   C1256369:insulin secretion [Cell Function]
   745   C1327616:Cell secretion [Cell Function]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
Processing 00000000.tx.141: J Biol Chem274 :6360 6365,1999[Abstract/Free FullText] Henquin JC: Regulation of insulin release by ionic and electrical events in beta-cells. 

Phrase: "J Biol Chem274"

Phrase: ":"

Phrase: "6360 6365,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Henquin JC"

Phrase: ":"

Phrase: "Regulation of insulin release"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "by ionic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0022023:Ion [Element, Ion, or Isotope]
   928   C1700702:ION [Functional Concept]

Phrase: "and"

Phrase: "electrical events in beta-cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441471:Events [Event]
   760   C3541888:Events [Classification]
Processing 00000000.tx.142: Horm Res27 :168 178,1987[Medline] Spinas GA: The dual role of nitric oxide in islet beta-cells. 

Phrase: "Horm Res27"

Phrase: ":"

Phrase: "168 178,"

Phrase: "1987"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Spinas GA"

Phrase: ":"

Phrase: "The dual role of nitric oxide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in islet beta-cells."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   913   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   896 E C1522529:Islet Cell [Cell]
   867   C0030281:Beta cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.143: News Physiol Sci14 :49 54,1999[Abstract/Free FullText] Huypens P, Ling ZM, Pipeleers D, Schuit F: Glucagon receptors on human islet cells contribute to glucose competence of insulin release. 

Phrase: "News Physiol Sci14"

Phrase: ":"

Phrase: "49 54,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Huypens P,"

Phrase: "Ling ZM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0043445:ZM [Geographic Area]
   861   C2346517:zm [Quantitative Concept]

Phrase: "Pipeleers D,"

Phrase: "Schuit F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: ":"

Phrase: "Glucagon receptors on human islet cells"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0061352:Receptors, Glucagon [Amino Acid, Peptide, or Protein,Receptor]
   767   C0030280:Glucagon Cell [Cell]
   756 E C1415011:GLUCAGON RECEPTOR [Gene or Genome]
   753   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   753   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   750   C1514760:Receptor Cell [Cell]

Phrase: "contribute to glucose competence of insulin release."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   774   C1719133:Glucose/Insulin [Quantitative Concept]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0030685:Release [Health Care Activity]
   748   C0086035:Competence [Qualitative Concept]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1880177:Contribute [Activity]
   748   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.144: Diabetologia43 :1012 1019,2000[Medline] Zwalich WS, Kelley GG: The pathogenesis of NIDDM: the role of pancreatic beta-cell. 

Phrase: "Diabetologia43"

Phrase: ":"

Phrase: "1012 1019,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450318:1019 [Intellectual Product]

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zwalich WS,"

Phrase: "Kelley GG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018370:GG [Geographic Area]

Phrase: ":"

Phrase: "The pathogenesis of NIDDM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0543483:pathogenesis [Functional Concept]
   770   C0699748:Pathogenesis [Pathologic Function]

Phrase: ":"

Phrase: "the role of pancreatic beta-cell."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.145: Diabetologia38 :986 991,1995[Medline] Wu H, MacFarlane WM, Tadayyon M, Arch JR, James RF, Docherty K: Insulin stimulates pancreatic-duodenal homeobox factor-1 (PDX1) DNA binding activity and insulin promoter activity in pancreatic beta cells. 

Phrase: "Diabetologia38"

Phrase: ":"

Phrase: "986 991,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wu H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "MacFarlane WM,"

Phrase: "Tadayyon M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Arch JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "James RF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035448:RF [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0201660:RF [Laboratory Procedure]
   861   C0748398:RF [Finding]

Phrase: "Docherty K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ":"

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "pancreatic-duodenal homeobox factor-1"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0248419:pancreatic-duodenal homeobox factor-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0013303:Duodenal [Body Part, Organ, or Organ Component]
   804   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   804   C0242303:Homeo Box [Gene or Genome]
   804   C0598306:Homeo Box [Spatial Concept]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   733 E C1278921:Duodenum [Body Part, Organ, or Organ Component]

Phrase: "(PDX1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1427500:PDX1 [Gene or Genome]
  1000   C1826562:PDX1 [Gene or Genome]

Phrase: ")"

Phrase: "DNA binding activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C2266866:Binding Activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C1148673:DNA Binding [Genetic Function]

Phrase: "and"

Phrase: "insulin promoter activity in pancreatic beta cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C1145751:insulin activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.146: Biochem J344 :813 818,1999[Medline] Ferber S, Halkin A, Cohen H, Ber I, Einav Y, Goldberg I, Barshack I, Seijffers R, Kopolovic J, Kaiser N, Karasik A: Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. 

Phrase: "Biochem J344"

Phrase: ":"

Phrase: "813 818,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ferber S,"

Phrase: "Halkin A,"

Phrase: "Cohen H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ber I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Einav Y,"

Phrase: "Goldberg I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Barshack I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Seijffers R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kopolovic J,"

Phrase: "Kaiser N,"

Phrase: "Karasik A"

Phrase: ":"

Phrase: "Pancreatic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "duodenal homeobox gene 1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0017347:Homeo Box Gene [Gene or Genome]
   812   C0013303:Duodenal [Body Part, Organ, or Organ Component]
   812   C0017337:Gene [Gene or Genome]
   812   C0242303:Homeo Box [Gene or Genome]
   812   C0598306:Homeo Box [Spatial Concept]
   741 E C1278921:Duodenum [Body Part, Organ, or Organ Component]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "expression of insulin genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "ameliorates"

Phrase: "streptozotocin-induced hyperglycemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020456:Hyperglycaemia [Disease or Syndrome]
Processing 00000000.tx.147: Nat Med6 :568 572,2000[Medline] Patan G, Piro S, Rabuazzo AM, Anello M, Vigneri R, Purrello F: Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells. 

Phrase: "Nat Med6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1334499:MED6 [Gene or Genome]
   861   C1706552:MED6 [Gene or Genome]

Phrase: ":"

Phrase: "568 572,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Patan G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Piro S,"

Phrase: "Rabuazzo"

Phrase: "AM"

Phrase: ","

Phrase: "Anello M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Vigneri R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Purrello F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: ":"

Phrase: "Metformin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025598:Metformin [Organic Chemical,Pharmacologic Substance]

Phrase: "restores"

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "altered by chronic exposure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205191:chronic [Temporal Concept]
   770   C0274281:Exposure, NOS [Injury or Poisoning]
   770   C0332157:Exposure [Clinical Attribute]
   770   C0392747:Altered [Functional Concept]

Phrase: "to free fatty acids"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "or"

Phrase: "high glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ":"

Phrase: "a direct metformin effect on pancreatic beta-cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.148: Diabetes49 :735 740,2000[Abstract] Sabatini DD, Bench K, Barnatt RJ: Cytochemistry and electron microscopy: preservation of cellular ultrastructure and enzymatic activity by aldehyde fixation. 

Phrase: "Diabetes49"

Phrase: ":"

Phrase: "735 740,"

Phrase: "2000"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sabatini DD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538867:DD [Gene or Genome]

Phrase: "Bench K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Barnatt RJ"

Phrase: ":"

Phrase: "Cytochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010741:Cytochemistry [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "electron microscopy"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0026019:Electron Microscopy [Laboratory Procedure]
  1000   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   861   C0013852:Electron [Quantitative Concept]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C3463986:Electron [Bird]
   789 E C0013850:Electronic [Manufactured Object]
   789 E C0205288:Microscopic [Qualitative Concept]
   789 E C1547561:Electronic [Idea or Concept]

Phrase: ":"

Phrase: "preservation of cellular ultrastructure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033085:Preservation [Laboratory Procedure]
   770   C1514402:Preservation [Laboratory Procedure]

Phrase: "and"

Phrase: "enzymatic activity by aldehyde fixation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C2267219:Enzymatic Activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.149: J Cell Biol17 :19 58,1963[Abstract/Free FullText] Marselli L, Dotta F, Piro S, Santangelo C, Masini M, Lupi R, Realacci M, Del Guerra S, Mosca F, Boggi U, Purrello F, Navalesi R, Marchetti P: Th2 cytokines have a partial, direct protective effect on the function and survival of isolated human islets exposed to combined proinflammatory and Th1 cytokines. 

Phrase: "J Cell Biol17"

Phrase: ":"

Phrase: "19 58,"

Phrase: "1963"

Phrase: "[Abstract/Free FullText"

Phrase: "] Marselli L,"

Phrase: "Dotta F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Piro S,"

Phrase: "Santangelo C,"

Phrase: "Masini M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lupi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Realacci M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Del Guerra S,"

Phrase: "Mosca F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Boggi U,"

Phrase: "Purrello F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Navalesi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Marchetti P"

Phrase: ":"

Phrase: "Th2 cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "have"

Phrase: "a partial, direct protective effect on the function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "survival of isolated human islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]

Phrase: "exposed to combined proinflammatory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0205195:Combined [Qualitative Concept]
   737 E C0336789:Combine [Manufactured Object]

Phrase: "and"

Phrase: "Th1 cytokines."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.150: J Clin Endocrinol Metab86 :4974 4978,2001[Abstract/Free FullText] Federici M, Hribal M, Perego L, Ranalli M, Caradonna Z, Perego C, Usellini L, Nano R, Bonini P, Bertuzzi F, Marlier LN, Davalli AM, Carandente O, Pontiroli AE, Melino G, Marchetti P, Lauro R, Sesti G, Folli F: High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. 

Phrase: "J Clin Endocrinol Metab86"

Phrase: ":"

Phrase: "4974 4978,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Federici M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hribal M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Perego L,"

Phrase: "Ranalli M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Caradonna Z,"

Phrase: "Perego C,"

Phrase: "Usellini L,"

Phrase: "Nano R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bonini P,"

Phrase: "Bertuzzi F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Marlier LN,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0861352:LN [Neoplastic Process]
   861   C1428884:ln [Gene or Genome]

Phrase: "Davalli"

Phrase: "AM"

Phrase: ","

Phrase: "Carandente O,"

Phrase: "Pontiroli AE,"

Phrase: "Melino G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Marchetti P,"

Phrase: "Lauro R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Sesti G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Folli F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: ":"

Phrase: "High glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "apoptosis in cultured human pancreatic islets of Langerhans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0162638:Apoptosis [Cell Function]

Phrase: ":"

Phrase: "a potential role for regulation of specific Bcl family genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0680074:family role [Social Behavior]
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "toward an apoptotic cell death program."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C1159821:apoptotic program [Cell Function]
   812   C1709697:Program [Conceptual Entity]
   812   C2728259:Program [Pharmacologic Substance]
   812   C3484370:Program [Functional Concept]
   756   C0162638:apoptotic cell death [Cell Function]
Processing 00000000.tx.151: Diabetes50 :1290 1301,2000[Abstract/Free FullText]

Phrase: "Diabetes50"

Phrase: ":"

Phrase: "1290 1301,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

